TSS:Hg 28643.1

Basic information about the TSS

---

TSS ID: hg_28643.1 Species: human Chr: chr2		Start: 61193362 End: 61193366 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000498268.1 uc061jnd.1 Distance: 0 GeneID: 9736 HGNC/MGI_ID: HGNC:20066 UniProt_ID:

Gene_name: ubiquitin specific peptidase 34 Gene_symbol: USP34 Gene_synonyms: KIAA0570 KIAA0729 Gene_source: HGNC:20066

TATA-Box annotation

---

Distance to TSS:	15946
Nearest PromoterID:	NM_001321300
Entrez ID:	130872
Nearest Unigene:	Hs.655602
Nearest Refseq:	NM_152392
Nearest Ensembl:	ENSG00000173209
Gene Name:	ubiquitin specific peptidase 34
Gene Alias:	AHA1
Gene Description:	activator of HSP90 ATPase homolog 2
Gene Type:	protein-coding
CpG%:	0
GC%:	0.353234
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@USP34 p2@USP34 p3@USP34 p4@USP34 p5@USP34 p6@USP34 p7@USP34 p8@USP34
Sample		p1@USP34	p2@USP34	p3@USP34	p4@USP34	p5@USP34	p6@USP34	p7@USP34	p8@USP34
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.16	3.12	2.92	6.23	1.36	0.19	0.78	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.10	1.82	2.83	3.84	1.01	0.00	1.21	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.49	3.28	3.28	6.37	1.74	0.39	1.54	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.78	2.08	2.29	3.33	0.83	0.83	1.25	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.10	2.25	4.05	5.40	1.12	0.00	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.92	3.68	2.33	3.29	1.94	0.58	0.39	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.68	3.27	4.36	7.63	1.31	0.44	1.74	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	5.57	1.94	2.66	5.09	0.97	0.00	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.98	1.92	3.21	5.56	1.50	0.43	0.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.17	1.74	8.11	6.96	1.16	0.00	0.58	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	7.68	1.62	4.04	4.45	4.85	0.81	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	3.25	2.03	4.07	0.41	0.81	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.83	4.19	3.06	1.45	1.13	0.16	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.69	5.41	2.86	3.76	0.60	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.08	4.17	3.73	3.29	0.66	0.22	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.10	4.28	2.77	2.26	0.75	0.50	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.58	3.28	2.84	1.09	0.66	1.09	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.92	5.06	1.69	3.37	0.42	0.84	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	2.67	0.00	1.60	0.00	0.53	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.04	3.16	1.81	3.46	0.60	1.20	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.16	3.34	3.74	2.00	0.40	0.53	1.07	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.81	3.45	3.11	1.21	0.17	0.52	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.83	3.23	1.68	1.29	0.65	0.52	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.83	2.67	2.43	2.43	0.97	0.24	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.22	1.81	2.58	1.29	0.00	0.26	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.98	2.85	2.53	2.22	0.95	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	2.75	2.20	1.65	1.10	1.65	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.49	6.37	3.30	3.06	0.47	0.71	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.28	5.01	2.58	0.97	0.65	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.76	3.44	2.90	1.27	1.45	0.72	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.89	3.98	2.09	0.84	0.63	0.21	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	14.65	4.69	1.56	2.15	1.17	0.59	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.07	3.38	2.32	1.06	0.42	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.22	4.45	2.31	3.96	1.15	0.00	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.34	2.99	2.43	3.55	1.12	0.56	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.56	5.17	2.87	2.49	0.77	0.38	0.38	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.90	4.29	2.86	1.84	1.43	0.00	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.47	4.43	0.81	1.81	1.21	0.81	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.48	3.78	2.16	2.43	1.08	0.27	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.48	3.12	2.16	1.44	0.96	0.48	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	14.59	3.06	2.59	1.65	0.24	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.86	2.64	2.93	1.32	1.76	0.59	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.81	2.74	1.05	2.74	0.63	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.48	3.50	2.80	2.45	0.87	0.00	0.70	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.46	5.02	2.01	3.21	0.80	1.00	1.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.68	4.65	2.33	2.33	0.47	0.70	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.99	3.84	0.96	2.64	0.48	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.82	5.66	2.68	1.19	1.19	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.95	6.22	1.44	2.39	0.72	1.20	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.36	4.04	3.44	2.22	2.43	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.78	4.51	2.87	2.05	0.61	0.61	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.45	2.67	3.11	2.67	0.89	2.00	0.44	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	13.99	13.99	41.98	0.00	0.00	83.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	3.55	0.71	0.71	0.35	0.35	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	3.65	2.32	2.32	1.66	0.33	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	14.26	8.39	12.58	1.68	0.00	2.52	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	4.59	3.67	3.67	1.38	1.84	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.51	2.27	2.27	1.94	1.30	0.65	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.99	1.93	0.96	0.64	0.64	0.64	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.29	4.40	4.09	6.29	0.31	0.31	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	3.53	2.82	0.00	0.71	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.93	2.80	1.12	1.12	0.00	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	45.38	16.72	7.17	11.94	2.39	3.18	4.78	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	5.10	4.76	6.46	0.68	0.34	1.36	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	2.60	2.27	3.25	0.65	0.00	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.10	2.13	1.06	1.42	0.00	0.00	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	48.49	0.00	0.00	0.00	0.00	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	55.28	7.90	71.08	0.00	0.00	47.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.41	1.46	0.98	0.98	0.00	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	2.48	2.48	0.99	1.49	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.81	2.81	1.41	3.75	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.60	2.65	0.66	2.65	0.66	0.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.95	2.78	1.24	1.24	0.00	0.00	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.20	3.67	2.14	0.92	0.31	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	4.59	2.38	2.69	0.95	0.48	0.00	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	5.45	2.41	2.89	1.60	0.16	0.48	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	7.38	3.82	2.80	1.40	1.27	0.13	0.13	0.38
Adipocyte - omental, donor2	11474-119C7	3.74	2.24	0.00	0.00	0.00	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	5.69	3.01	1.34	0.67	1.00	0.00	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	4.47	0.64	1.28	1.91	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.61	0.90	0.45	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	5.73	2.78	0.87	0.70	0.52	0.35	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	11.34	6.65	4.30	4.11	1.96	0.78	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	12.61	10.30	4.89	1.29	1.80	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	14.22	3.90	4.74	0.84	2.23	1.12	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	11.76	5.88	1.18	0.59	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	10.46	8.61	7.64	1.37	1.29	0.88	0.32	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	14.52	5.16	4.84	1.61	0.32	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.13	4.27	2.67	0.53	0.53	0.00	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	2.78	1.11	0.56	0.00	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	8.73	3.74	1.66	1.25	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	8.29	5.02	3.52	1.00	0.75	1.00	0.25	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	13.09	2.95	2.29	0.98	1.31	0.00	0.65	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	9.44	4.26	3.04	0.00	0.61	0.61	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	0.88	1.10	0.22	0.22	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.36	1.08	0.72	0.00	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	1.20	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	4.86	1.62	1.26	0.36	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.26	1.03	0.62	1.44	0.00	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	5.61	2.52	3.43	1.14	1.14	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	2.45	0.98	3.92	0.49	0.73	0.73	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.15	0.45	2.70	3.15	0.00	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1.30	1.30	2.60	1.30	0.43	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.39	1.20	2.09	2.09	0.30	0.00	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	2.53	1.26	1.26	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	0.66	1.98	1.32	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1.95	2.92	1.30	1.30	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	0.49	3.40	1.46	1.46	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1.19	1.19	0.59	0.59	0.00	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1.13	1.51	0.38	1.13	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1.45	2.90	0.00	1.45	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	0.00	1.25	0.00	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	2.47	1.48	2.14	0.82	0.66	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1.36	0.00	1.36	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1.66	1.21	1.81	0.90	0.15	0.00	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1.61	1.07	1.61	1.61	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	2.27	2.46	1.70	1.32	0.19	0.00	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	2.94	0.53	1.34	1.60	0.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1.95	0.98	1.95	1.95	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	2.32	1.66	1.66	1.33	0.17	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	2.23	3.26	2.40	1.89	0.34	0.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1.94	0.97	0.49	0.97	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1.52	2.28	1.90	0.76	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1.21	2.42	1.21	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	2.28	0.57	1.71	0.57	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	2.14	1.71	1.07	1.28	0.43	0.21	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1.03	0.26	0.26	0.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1.41	1.41	2.35	1.41	0.47	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	0.96	1.61	1.29	1.29	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	0.71	1.43	0.00	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	0.58	1.75	0.58	0.00	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1.81	4.52	1.20	1.81	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	0.00	2.38	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	0.51	2.03	2.03	2.54	0.00	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	2.80	2.80	1.27	0.25	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	1.91	0.00	1.27	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	3.02	0.86	0.86	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1.06	1.48	1.27	0.42	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.03	1.45	0.29	0.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	0.94	3.78	2.83	0.00	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	1.36	3.90	1.86	0.51	0.85	0.00	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	2.11	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1.50	3.00	1.29	0.86	0.21	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	0.60	0.60	1.80	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	0.00	1.46	1.46	2.92	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	1.15	1.61	0.69	1.61	0.46	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	0.00	2.55	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	2.29	1.53	1.02	1.02	0.00	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1.24	1.65	1.24	1.45	0.21	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2.45	1.22	1.84	0.92	0.31	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1.91	1.43	1.91	1.91	0.00	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.00	0.89	1.11	1.77	0.44	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	0.00	0.00	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1.66	1.66	2.22	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	2.91	2.12	0.53	1.85	0.00	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	2.54	0.36	1.09	0.00	0.00	0.00	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	0.98	1.60	0.49	0.74	0.61	0.12	0.49	0.12
Astrocyte - cerebellum, donor2	11580-120F5	1.88	1.37	0.34	0.51	0.00	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	1.89	1.05	0.63	0.00	0.84	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	8.02	5.23	5.23	3.83	3.14	0.70	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	11.00	6.79	4.53	3.24	1.94	0.81	1.29	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	10.44	5.22	7.01	2.98	2.98	0.75	0.75	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	32.11	6.54	6.42	6.77	1.26	1.15	1.83	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.56	8.39	5.26	5.14	1.50	1.00	1.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	29.36	7.40	5.92	5.58	1.93	1.37	1.37	0.46
Basophils, donor1	12241-129G9	14.65	7.06	2.09	4.45	0.52	0.26	0.00	0.78
Basophils, donor2	12242-129H1	28.14	6.13	7.58	8.66	4.33	0.00	1.08	0.72
Basophils, donor3	12243-129H2	15.88	7.06	5.59	3.09	2.20	1.03	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	0.65	0.65	0.00	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.46	2.29	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	1.26	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.87	1.46	0.42	0.42	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	0.23	0.69	0.46	0.23	0.23	0.46	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	3.42	4.86	0.90	1.80	0.00	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	13.29	14.94	13.19	15.36	6.70	1.03	5.05	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.67	9.55	15.37	13.04	4.19	2.33	5.59	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	27.82	9.59	2.56	0.32	1.60	0.32	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	41.37	20.68	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	31.00	12.40	7.33	1.69	4.51	1.13	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	35.08	12.44	4.08	4.27	1.30	1.67	1.11	0.74
CD14+ Monocytes, donor3	11381-118B4	33.81	10.98	6.59	3.29	1.76	0.22	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	10.19	16.98	5.38	0.85	1.98	0.57	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.61	11.37	4.93	1.90	3.79	0.76	0.76	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	15.78	22.35	10.85	1.97	1.31	0.66	0.66	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	20.38	8.96	4.19	2.46	1.59	2.02	1.45	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	19.92	10.86	3.62	1.81	1.21	2.11	0.91	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	28.90	13.27	4.03	2.61	1.66	0.71	0.47	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.89	7.20	2.51	1.51	1.00	0.67	1.17	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	17.39	9.11	2.21	2.21	1.93	1.10	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.37	10.91	1.74	2.73	1.24	1.74	1.24	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	11.36	7.24	3.52	2.35	0.78	0.20	0.39	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.96	6.77	2.67	1.07	1.25	0.71	0.71	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	15.67	9.79	2.61	1.31	1.09	1.09	0.44	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.58	6.32	4.68	1.40	0.70	1.17	1.17	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	22.71	11.09	4.75	3.17	1.58	0.53	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	11.09	5.55	1.11	2.22	0.00	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.49	5.95	2.68	1.49	1.19	1.19	0.74	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.36	6.39	3.59	1.40	1.20	1.20	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.24	7.70	3.33	3.96	0.62	1.04	0.00	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.85	9.84	4.58	2.75	2.52	0.69	1.14	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.85	13.57	2.94	2.71	2.26	0.68	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.53	9.17	1.75	1.31	0.87	1.31	0.87	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.99	7.26	2.15	2.69	2.42	0.54	1.08	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	18.84	8.20	4.88	1.74	1.74	0.87	1.57	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	25.25	10.10	3.79	1.26	0.84	1.26	0.42	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.84	8.82	2.76	2.39	1.10	0.73	1.47	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.43	14.09	3.17	2.11	1.41	2.11	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.20	16.23	3.07	3.51	0.44	1.32	0.88	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.43	6.10	4.01	1.74	1.57	0.87	0.52	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	14.12	8.18	1.86	3.72	1.12	0.74	1.12	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.95	12.29	6.47	2.59	1.94	0.86	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	8.19	2.46	0.82	2.05	1.23	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.52	8.81	2.32	2.09	0.70	0.46	1.62	1.85
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.37	7.19	2.78	2.32	1.62	0.23	0.46	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	9.37	3.49	2.83	0.87	0.65	0.44	0.65	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	12.01	2.54	3.46	1.62	0.23	1.15	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	9.10	4.77	1.95	0.87	0.43	0.43	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	16.51	10.43	4.98	1.71	1.71	1.71	1.09	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	14.67	5.41	2.27	1.22	1.40	0.35	1.05	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	25.86	15.16	5.35	2.45	1.78	0.22	0.22	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	15.57	3.06	3.06	1.53	0.51	0.00	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	14.05	3.07	2.20	0.88	0.88	0.44	0.66	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	13.69	6.11	1.89	1.68	1.05	0.21	0.21	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	24.39	6.10	2.03	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.05	18.31	3.39	2.71	2.71	0.68	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	12.43	4.14	3.11	4.14	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	33.58	19.72	3.73	7.46	3.73	1.07	1.60	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.59	26.27	6.43	2.14	5.90	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	20.36	18.25	3.51	5.62	2.81	0.70	1.40	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	12.55	1.57	3.92	2.35	1.57	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	29.00	21.09	1.32	3.95	3.95	2.64	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	66.57	27.12	9.86	13.97	5.75	4.11	3.29	2.47
CD19+ B Cells, donor2	11624-122B4	51.51	26.84	12.33	15.96	5.80	3.63	2.18	1.45
CD19+ B Cells, donor3	11705-123B4	55.53	23.22	10.10	14.14	7.07	2.52	2.02	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	19.80	3.23	8.89	10.10	2.02	0.81	0.81	3.64
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.19	2.40	4.79	5.19	0.40	0.80	2.00	1.20
CD34+ Progenitors, donor1	11545-120B6	13.05	9.04	3.01	1.00	2.01	4.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.80	10.11	3.93	10.67	7.87	3.37	1.12	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.78	7.14	3.76	1.13	4.51	1.13	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	18.72	7.44	3.83	2.48	3.38	1.58	1.35	0.45
CD4+ T Cells, donor1	11225-116C1	112.47	28.56	7.14	14.28	7.14	3.21	3.21	2.50
CD4+ T Cells, donor2	11306-117C1	98.59	22.66	5.51	9.19	4.90	5.51	6.12	1.22
CD4+ T Cells, donor3	11382-118B5	66.79	15.25	6.10	9.45	5.79	1.83	7.01	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	39.56	3.83	9.19	8.17	2.81	0.51	1.53	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	47.39	3.37	10.11	9.43	1.80	1.12	1.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	44.56	2.30	9.20	11.50	2.30	1.15	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	41.72	15.17	7.11	5.69	4.74	0.47	1.42	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	48.46	16.15	7.02	9.83	7.02	2.11	3.51	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	13.18	9.89	9.89	3.30	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.46	3.90	8.09	7.37	2.31	0.43	1.16	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.86	3.56	7.46	5.59	1.53	0.34	1.53	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	28.05	2.90	5.80	5.48	0.64	0.81	1.13	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.04	7.17	7.17	6.28	3.59	0.00	3.59	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	31.44	7.69	5.94	10.83	3.14	0.00	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.80	10.12	12.32	12.76	4.40	0.88	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	26.99	2.95	5.06	9.28	0.00	0.84	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.75	1.87	7.06	5.19	1.45	0.42	2.29	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.06	2.00	4.01	3.01	1.00	0.00	1.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	43.78	21.21	2.72	4.89	2.72	0.27	2.99	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	64.31	28.94	5.90	9.11	4.82	2.14	3.22	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	78.90	21.52	0.00	7.17	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	39.68	4.08	7.23	7.97	3.15	1.11	2.41	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	31.84	3.25	8.66	5.85	1.30	0.65	0.65	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	33.41	4.41	10.72	7.15	1.68	0.84	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	43.48	15.17	6.07	7.58	7.08	1.52	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	35.53	10.83	3.47	8.23	3.47	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.94	15.25	7.41	10.90	3.05	0.00	0.44	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	41.07	16.83	6.93	8.41	3.96	1.48	1.48	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	49.85	10.16	12.92	5.54	2.77	1.85	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	29.31	9.77	4.19	5.58	5.58	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	39.05	21.32	6.37	8.31	8.31	1.38	2.77	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	31.66	18.40	9.82	11.29	6.38	1.72	1.23	2.21
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	30.80	13.86	6.16	10.78	4.62	3.08	1.54	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	54.43	18.26	9.67	7.88	7.16	1.43	1.07	2.86
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	60.94	6.92	12.46	8.31	8.31	0.00	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	73.66	11.79	10.80	12.44	9.17	1.64	5.89	3.27
CD8+ T Cells, donor2	11307-117C2	76.96	6.76	9.76	9.76	4.51	3.00	6.38	2.63
CD8+ T Cells, donor3	11383-118B6	113.87	13.63	13.38	16.66	4.04	5.05	2.78	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.82	7.34	0.69	1.15	0.23	0.23	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2.88	3.83	0.72	2.64	0.24	0.24	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.56	3.28	0.55	2.46	0.00	0.27	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.80	3.90	0.60	1.50	0.00	0.30	0.60	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.88	6.72	0.24	1.68	0.24	0.24	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.55	4.32	0.23	0.68	0.23	0.23	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.48	2.82	0.43	1.52	0.00	0.00	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.21	4.74	0.00	1.32	0.26	0.00	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.52	4.69	0.23	2.11	0.23	0.47	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.83	3.32	0.30	1.81	0.00	0.91	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.52	3.78	0.87	1.45	0.58	0.00	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.80	3.20	0.53	2.13	0.00	0.00	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.13	2.63	0.44	0.88	0.00	0.00	0.88	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	5.47	1.82	2.73	0.46	0.46	0.46	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	7.46	0.75	1.49	0.75	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.32	5.40	1.44	1.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.18	5.18	1.15	1.73	0.00	0.29	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.06	3.77	1.18	0.24	0.24	0.00	0.47	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	6.97	0.63	1.90	0.32	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	6.15	4.92	0.92	1.54	0.00	0.00	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.17	5.77	0.96	0.32	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.68	1.91	0.00	2.29	0.00	0.38	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	6.31	3.15	0.39	1.97	0.00	0.39	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	1.51	0.00	0.00	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	6.42	7.23	3.21	2.41	0.80	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.79	9.09	0.70	1.40	0.00	0.70	5.60	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	8.01	8.01	1.00	5.01	0.00	1.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	34.73	12.79	1.83	0.00	1.83	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	3.46	1.98	1.98	0.99	0.49	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	3.37	1.79	1.89	2.10	0.95	0.21	0.00	0.53
Chondrocyte - de diff, donor1	11261-116G1	3.12	2.77	1.39	1.04	1.73	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	4.26	2.13	1.78	1.07	0.71	1.07	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	5.35	1.48	2.28	0.91	0.46	0.11	0.46	0.00
Chondrocyte - re diff, donor2	11339-117F7	1.79	6.27	0.90	3.58	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.28	6.47	1.62	0.00	0.81	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	12.28	6.43	6.20	4.93	2.52	0.69	0.34	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	9.19	3.42	3.63	4.06	1.92	0.86	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	10.89	6.19	5.22	4.42	1.68	1.06	1.50	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	19.81	6.97	3.85	3.94	3.94	2.38	0.83	0.73
Corneal Epithelial Cells, donor1	11526-119I5	0.44	0.66	0.44	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1.14	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.79	0.26	0.26	0.00	0.00	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.58	4.62	2.97	3.14	0.83	0.50	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.72	6.62	4.10	2.21	0.95	0.00	1.89	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	10.35	3.45	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.10	4.32	2.59	0.97	0.65	0.32	0.22	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.82	14.69	4.10	2.05	1.37	1.37	0.34	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.85	9.14	3.26	1.31	2.61	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.49	15.49	4.36	0.00	5.32	2.42	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	1.33	2.50	1.00	1.17	0.50	0.67	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	0.00	2.93	1.76	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.96	1.98	0.57	0.28	0.57	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	3.54	3.54	2.36	0.39	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.07	1.45	0.58	0.58	0.29	0.29	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	5.41	3.06	2.35	1.65	0.47	0.71	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	3.33	1.58	0.88	0.70	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.53	6.21	3.55	2.88	1.11	0.22	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.91	7.00	7.61	3.65	1.83	0.91	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.38	9.87	4.51	5.36	1.69	0.56	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	0.89	2.38	0.89	0.59	0.30	0.00	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	1.56	0.52	0.52	2.60	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	3.69	1.42	0.99	1.13	0.57	0.43	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	1.60	2.80	2.00	4.40	0.80	0.40	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	1.05	0.00	0.00	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	18.64	6.83	8.82	4.47	3.23	0.87	1.24	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.86	10.43	5.87	1.96	1.30	1.09	0.65	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	23.69	12.70	5.25	2.20	1.95	0.61	0.49	0.37
Endothelial Cells - Vein, donor1	11267-116G7	1.14	2.28	2.28	0.00	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	1.40	4.19	0.70	0.00	0.70	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	4.87	5.34	3.77	0.63	1.10	0.16	0.16	0.31
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	127.07	26.40	31.35	11.55	1.65	4.95	3.30
Eosinophils, donor3	12246-129H5	24.97	114.14	17.83	14.27	3.57	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	0.73	0.98	0.24	0.49	0.00	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.37	1.64	5.75	3.28	0.82	0.41	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	0.88	0.66	0.33	0.33	0.00	0.11	0.00	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.47	1.08	1.19	0.33	0.22	0.00	0.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	4.97	2.79	4.12	2.18	0.73	0.24	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.19	12.01	11.87	6.55	1.36	0.14	2.59	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	5.80	2.43	1.90	1.48	0.63	0.32	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	6.32	6.59	6.32	6.06	0.79	1.84	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	10.30	2.66	2.33	0.66	1.00	0.66	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	3.18	2.27	2.72	0.00	0.45	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	1.52	0.76	0.76	0.00	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	4.89	1.42	1.73	1.10	0.16	0.47	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	14.85	12.12	7.88	3.33	1.52	0.30	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	4.95	3.93	4.44	2.79	0.51	0.38	0.25	0.38
Fibroblast - Cardiac, donor6	11460-119B2	4.70	2.88	2.43	1.21	0.76	0.61	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	0.94	0.94	1.47	0.54	0.00	0.13	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	0.43	3.88	3.02	1.73	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	4.39	2.93	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	1.61	2.08	1.38	1.15	0.23	0.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	7.12	2.37	2.88	2.71	1.70	0.51	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	3.52	4.23	2.82	1.17	0.23	0.23	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	0.47	3.30	0.47	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	3.87	2.78	1.69	0.97	0.48	0.00	0.00	0.24
Fibroblast - Dermal, donor4	11450-119A1	4.97	6.22	2.15	1.02	0.45	0.34	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	5.06	5.23	2.27	1.05	0.87	0.35	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	3.57	4.55	2.60	2.44	1.46	0.16	1.62	0.16
Fibroblast - Gingival, donor1	11237-116D4	12.29	5.00	10.83	3.54	1.04	0.21	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.77	8.12	6.81	2.10	1.57	1.31	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	9.09	4.48	3.95	2.11	1.19	0.13	0.26	0.26
Fibroblast - Gingival, donor3	11394-118C8	16.24	7.93	6.09	1.35	0.97	1.55	0.19	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	7.27	7.27	6.23	3.12	2.08	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.34	3.52	4.05	1.06	0.88	0.88	0.35	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.94	5.92	4.83	1.87	0.47	0.00	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.71	3.52	3.92	1.49	1.22	0.54	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	45.52	25.41	2.12	0.35	0.00	1.41	0.00	2.82
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.70	4.68	5.70	1.61	0.58	0.88	0.00	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.95	4.23	4.77	1.91	1.09	0.55	0.55	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	13.27	6.36	6.36	1.65	1.10	0.55	0.22	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	16.29	8.66	6.16	1.61	2.35	2.79	0.29	0.59
Fibroblast - Lung, donor1	11270-116H1	0.00	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	8.95	4.48	2.98	2.98	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	5.70	1.69	2.53	0.84	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	2.50	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	3.65	2.44	2.44	0.41	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.01	5.82	6.60	1.94	1.16	0.39	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	14.26	8.80	2.88	1.52	1.82	1.06	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	12.24	9.18	6.73	4.28	1.22	0.31	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.01	2.29	2.67	2.29	0.38	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	5.13	1.89	2.16	1.08	0.81	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.79	6.26	3.94	0.81	1.16	0.58	0.12	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	2.54	0.77	2.10	0.99	0.55	0.11	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	2.64	2.03	1.22	0.20	0.00	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	0.67	1.34	0.67	0.00	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.95	1.98	1.98	0.40	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.13	5.95	3.97	4.96	1.19	0.79	2.18	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	5.86	3.20	3.73	1.60	1.60	0.53	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	6.31	4.14	3.35	1.97	0.79	0.20	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	2.71	3.01	3.61	3.01	0.30	0.60	0.60	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	3.99	3.56	3.02	1.94	1.30	0.54	0.43	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.85	4.05	4.05	4.05	0.76	0.00	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	7.06	1.80	3.61	1.48	0.82	0.33	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.45	6.62	8.62	5.61	1.00	0.60	2.21	0.20
Fibroblast - skin normal, donor2	11561-120D4	3.11	4.42	3.21	2.21	0.80	0.20	0.40	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	10.88	8.46	4.53	8.16	2.12	0.30	0.91	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.12	3.40	4.23	1.82	0.91	0.58	0.25	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	3.42	3.93	1.20	2.39	1.20	0.34	1.03	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.24	1.97	3.28	1.97	0.66	0.00	1.97	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	3.30	1.92	2.98	2.13	1.70	0.53	0.53	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	3.71	1.52	2.19	0.84	0.84	0.17	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.65	2.67	2.51	1.73	0.78	0.31	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	39.22	5.23	10.46	4.36	0.87	3.49	3.49	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	2.60	4.16	3.64	1.91	0.69	0.17	0.17	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	4.42	6.51	3.12	3.38	0.78	0.52	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.13	11.24	4.34	2.81	1.53	0.77	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1.53	0.77	0.77	3.83	2.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1.91	0.00	3.19	1.91	1.91	0.00	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	11.41	4.85	9.13	9.41	3.99	2.00	1.43	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.78	6.89	7.45	11.86	4.69	2.48	1.10	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	17.12	3.42	3.42	6.16	4.57	1.60	1.14	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	11.49	4.36	4.76	8.12	2.77	2.58	0.99	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	10.84	6.08	5.02	9.25	3.17	4.23	1.06	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.39	3.26	7.50	7.18	5.87	2.94	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.84	3.54	7.08	7.96	2.21	0.88	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.51	2.54	5.94	5.51	3.39	0.71	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	7.51	4.19	5.91	5.54	2.71	0.62	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.10	0.81	2.95	4.03	1.88	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	3.22	3.22	4.71	3.35	1.49	0.37	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	4.29	3.88	5.81	5.81	2.35	0.14	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	3.05	1.83	3.25	5.08	2.64	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	3.88	2.97	3.19	2.74	2.05	0.23	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	4.11	4.11	5.85	5.11	1.74	0.25	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.12	3.28	6.34	4.59	2.19	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	4.43	1.18	5.02	4.14	2.66	0.59	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	6.52	4.13	4.45	5.09	3.02	0.48	0.64	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	6.48	3.57	3.57	4.24	2.01	1.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	6.25	2.02	4.03	3.23	1.41	0.40	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	6.11	3.39	5.94	3.05	3.22	1.19	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	5.23	3.64	4.52	5.05	4.08	0.80	0.27	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.84	3.33	3.64	4.58	3.95	0.73	0.52	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.98	3.42	4.61	2.22	3.42	0.51	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	8.19	2.10	5.75	3.21	4.98	1.00	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.57	3.16	3.58	3.58	2.83	0.75	0.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	3.68	3.27	1.23	4.08	1.84	0.82	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	5.57	1.86	4.54	3.71	2.68	0.62	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.11	2.88	6.11	4.38	5.53	0.46	0.12	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	8.00	3.17	4.17	2.50	1.83	1.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.05	2.42	5.07	1.98	2.65	1.32	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	5.66	2.58	6.64	4.06	3.20	0.74	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.43	2.76	3.40	2.76	3.40	0.81	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	8.34	2.89	5.77	3.21	3.85	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	8.81	2.46	5.59	2.84	1.90	0.85	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	6.49	2.53	2.37	1.42	1.42	0.63	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.73	2.43	1.82	4.26	1.82	1.52	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	7.74	3.45	4.39	2.09	2.93	0.84	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.32	1.76	3.51	2.63	0.88	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	9.26	1.68	2.52	3.09	3.37	0.28	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	8.06	2.87	6.57	2.41	2.13	0.65	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	7.49	1.87	0.53	2.41	0.80	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	8.42	2.60	3.98	1.84	1.22	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	7.38	1.81	5.44	1.68	1.30	0.52	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.66	1.36	3.80	1.63	1.90	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.66	2.21	4.42	3.69	1.84	0.37	0.92	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	8.55	1.54	5.92	2.19	1.10	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	2.98	9.92	1.98	1.98	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.37	1.71	4.75	3.43	1.98	0.40	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	7.47	4.04	5.25	2.82	1.41	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	12.45	6.10	4.07	1.78	3.05	0.51	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	3.78	3.78	3.38	13.54	4.18	0.60	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	4.93	3.08	3.85	5.85	2.31	0.92	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	5.93	4.50	7.98	11.87	3.68	0.00	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1.88	2.19	2.50	3.13	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.85	0.28	1.41	4.24	0.28	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	2.31	4.61	11.07	2.77	0.92	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	7.42	9.90	0.00	7.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3.48	2.32	4.25	5.03	3.09	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1.60	6.42	0.00	6.42	3.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	3.48	6.96	6.96	0.00	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4.56	2.93	5.53	7.81	1.95	0.98	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.94	1.24	4.94	8.65	1.65	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	6.66	13.33	0.00	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3.92	1.40	5.03	6.15	1.12	1.12	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	2.94	1.96	2.61	6.54	3.60	0.33	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	5.03	5.87	15.94	0.00	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	3.50	2.86	6.36	6.68	1.59	0.64	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.40	2.72	2.72	5.09	0.68	0.34	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	2.09	8.35	14.62	12.53	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1.72	1.72	4.01	2.86	4.01	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1.18	2.66	3.26	4.14	1.78	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	10.16	11.86	11.86	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	6.21	2.90	3.31	9.53	1.66	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	5.29	2.07	2.76	4.83	1.61	0.23	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	5.27	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	5.38	1.92	5.00	3.08	2.31	0.77	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.54	2.61	4.56	7.50	1.96	0.65	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.68	1.34	2.68	4.01	1.34	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	2.31	3.85	3.08	7.32	3.85	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.04	4.11	4.79	9.24	2.05	1.37	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	9.94	14.91	24.85	2.48	2.48	7.45	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	4.72	1.89	11.32	5.19	3.30	0.94	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	1.21	3.62	3.02	2.41	1.21	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.14	3.05	1.53	8.65	2.54	1.02	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	7.98	3.99	5.58	7.98	3.99	0.80	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	6.91	1.97	8.39	7.89	5.43	0.99	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	3.54	4.72	9.44	16.53	8.26	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	5.83	1.75	2.33	7.00	2.33	0.00	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.02	6.58	8.34	6.14	4.39	0.00	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.09	3.39	4.24	9.32	3.39	1.70	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1.19	1.19	2.39	5.97	1.79	0.60	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	3.88	2.91	3.88	3.40	0.49	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	0.00	1.14	2.28	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.24	1.25	1.25	1.66	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4.50	1.12	1.12	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.76	0.95	0.95	0.00	0.00	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	0.42	0.84	0.00	0.00	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	5.57	1.04	1.62	0.93	0.00	0.12	0.35	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	6.25	2.36	1.69	1.52	0.34	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.05	0.68	1.37	1.14	0.23	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.25	1.53	2.30	1.20	0.11	0.00	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.37	1.93	0.43	0.86	0.64	0.00	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	5.38	1.08	1.29	0.43	0.00	0.22	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	4.36	1.74	1.37	1.37	0.12	0.12	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.15	1.03	1.20	0.51	0.00	0.00	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4.49	1.28	1.60	1.60	0.32	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.36	1.68	0.00	0.00	1.12	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.73	1.73	0.00	0.00	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1.76	0.71	0.71	1.76	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	0.00	1.45	0.00	0.00	0.73	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	1.75	1.05	1.40	0.52	0.17	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	29.05	4.84	0.00	2.42	0.00	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	9.70	9.70	1.08	3.23	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	30.06	9.82	2.45	4.91	1.23	0.00	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	14.36	6.53	1.96	1.31	2.61	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	8.56	2.80	4.72	8.39	1.22	0.35	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.39	3.02	2.33	1.65	0.69	0.14	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	0.00	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	3.25	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	1.67	0.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	2.65	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	4.43	0.00	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	0.63	0.63	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	4.52	2.58	0.65	0.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	1.61	0.00	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	0.81	0.00	0.81	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.52	2.94	0.42	0.84	0.42	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	1.61	0.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	0.92	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	1.89	0.94	0.00	0.00	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	2.72	0.91	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	0.00	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	2.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	2.55	1.28	0.00	0.00	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	0.00	0.00	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	9.28	1.43	2.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.17	0.93	0.00	0.62	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	3.48	2.78	0.00	0.70	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	0.00	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	1.74	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	0.00	1.07	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	2.20	2.12	1.06	1.71	0.41	0.08	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	0.00	3.51	0.00	1.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	2.93	2.27	2.75	2.56	0.28	0.09	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	5.68	3.52	2.61	2.38	0.11	0.34	0.23	0.00
Keratocytes, donor1	11527-119I6	1.72	0.69	0.69	1.72	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	0.00	0.00	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	6.13	2.17	5.34	1.38	0.79	0.00	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	46.16	4.40	0.00	2.20	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	0.00	3.24	0.00	1.08	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	3.92	3.00	4.04	2.19	2.31	0.69	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	8.88	8.38	4.34	3.33	0.50	0.40	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	3.44	2.02	1.19	0.95	0.36	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.35	0.84	0.56	0.28	0.00	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.14	1.73	1.89	3.15	0.79	0.63	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.76	0.54	1.08	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	1.89	0.32	0.95	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.62	0.54	0.54	0.43	0.11	0.22	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.51	2.46	0.00	2.05	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.02	1.52	0.25	0.76	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.80	0.56	0.56	1.97	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	1.19	2.77	1.19	1.58	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.10	1.74	1.55	0.97	0.39	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.85	0.37	0.00	0.56	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	3.48	1.39	2.79	1.05	0.00	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.15	0.48	0.72	0.95	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.61	0.55	0.55	0.55	0.27	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	4.00	0.62	1.54	1.23	0.31	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	0.94	0.31	0.62	1.25	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.29	0.55	0.55	0.91	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.29	1.97	0.66	2.63	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.05	0.59	0.88	0.88	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.00	0.75	0.50	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1.94	2.42	0.97	0.97	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.50	0.81	1.35	1.08	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.94	1.21	0.00	0.61	0.30	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	1.04	0.52	0.52	0.00	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.98	1.26	1.05	3.14	0.42	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.16	0.75	0.00	0.30	0.15	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.06	0.69	2.06	1.38	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	2.07	1.13	0.38	0.56	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.59	0.53	0.74	0.53	0.00	0.21	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	1.94	0.97	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	1.65	1.65	0.00	1.32	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.23	0.25	0.25	0.37	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.92	1.85	1.48	4.07	0.37	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.72	1.48	0.74	0.74	0.74	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.79	0.69	0.00	0.41	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	3.86	2.25	0.96	0.96	0.64	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	1.52	3.04	1.22	2.13	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3.36	2.24	1.40	2.10	0.00	0.56	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1.42	1.07	0.36	1.42	0.36	0.71	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.94	2.42	0.00	0.48	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.71	0.47	0.47	0.78	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	1.43	0.36	0.36	0.72	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.94	0.98	0.33	0.65	0.65	0.00	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.71	0.24	0.47	0.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2.97	2.48	0.99	1.11	0.62	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.02	1.54	0.00	0.00	0.26	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.09	1.19	0.90	0.60	0.30	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	9.06	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	3.07	0.00	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.91	2.97	0.00	0.74	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.23	1.69	0.85	0.42	0.42	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	1.41	1.41	0.00	0.00	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	1.87	0.93	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	3.61	1.03	0.00	2.06	0.00	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	3.57	1.19	1.19	0.00	0.00	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.20	3.62	0.45	1.81	0.23	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.82	0.87	0.58	2.33	0.87	0.58	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.45	2.70	0.45	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.94	2.44	0.27	1.49	0.95	0.41	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.81	1.54	0.51	1.54	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.70	2.82	1.41	0.00	0.00	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.66	0.67	0.00	2.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.68	2.04	1.02	0.51	1.02	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.81	2.13	2.13	3.20	0.80	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.96	2.27	2.27	1.89	0.57	0.76	0.38	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.20	1.23	0.00	1.23	1.84	0.61	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.94	4.08	2.45	1.63	0.00	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.83	2.08	1.04	1.25	0.42	0.62	0.42	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.57	1.12	1.40	1.40	0.28	0.56	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	2.06	2.06	2.06	1.03	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.61	2.61	0.87	4.35	0.87	1.16	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	0.60	0.00	1.20	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.17	3.32	2.77	2.77	0.00	0.55	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	9.54	2.47	0.71	1.77	0.00	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.48	0.74	1.11	1.48	0.74	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	2.30	0.00	2.30	1.15	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	1.54	1.54	2.30	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.23	2.83	0.00	2.26	1.13	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	1.64	3.28	1.64	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.04	1.36	1.36	2.26	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	2.87	0.72	0.72	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.20	4.48	0.00	2.24	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.43	4.09	0.74	2.60	0.37	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.74	0.86	0.86	3.02	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	2.57	0.00	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	7.00	2.00	0.67	2.00	0.00	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.86	1.21	0.60	3.62	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	0.71	0.71	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.31	1.37	0.34	2.41	0.69	0.34	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	0.54	1.07	1.61	0.54	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	2.69	1.35	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.63	3.33	2.22	3.70	0.37	0.74	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	2.33	0.00	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	2.12	2.12	1.06	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.20	0.80	2.40	1.60	0.00	0.80	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	7.27	1.45	0.00	0.73	0.73	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	2.30	0.00	0.77	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.89	1.97	0.99	1.48	0.00	0.00	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	2.82	0.00	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	2.51	2.01	1.51	1.01	0.00	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.11	3.60	2.25	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	0.00	0.00	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.69	5.79	2.67	1.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.38	3.13	2.35	2.74	0.39	0.00	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.90	3.30	1.32	1.98	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.57	5.71	1.56	2.59	1.04	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	4.81	1.31	2.63	0.00	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	2.24	2.24	0.56	1.68	0.00	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	5.74	2.21	0.44	0.00	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.26	3.47	1.16	1.93	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.13	0.51	1.01	3.04	0.51	0.51	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	2.40	0.48	0.48	0.00	0.48	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.73	2.78	1.19	0.40	0.80	0.40	0.00	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.90	1.22	0.00	3.04	1.22	0.61	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	2.08	0.00	0.69	1.38	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.88	3.80	2.28	2.66	0.38	1.52	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.30	0.52	0.52	1.03	0.52	0.52	0.52	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.23	3.02	1.21	1.21	1.81	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.14	1.58	1.90	3.17	0.00	0.63	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.60	1.07	0.53	1.60	0.00	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	5.75	1.15	0.57	1.15	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	15.94	2.57	2.57	4.11	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	0.00	0.00	0.71	0.00	0.00	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	2.84	0.57	2.84	2.27	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.74	3.74	0.83	1.25	1.25	0.00	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	0.78	0.78	0.78	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.76	5.43	0.84	2.09	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	4.65	2.79	0.93	2.32	0.00	0.00	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.68	0.00	0.67	2.68	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	4.28	1.60	1.07	2.67	0.53	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.68	2.02	1.21	3.64	1.21	0.81	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	1.84	0.92	0.92	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	3.56	0.89	2.67	0.00	0.89	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.84	3.42	0.57	2.28	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	5.37	0.77	1.53	3.83	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.02	1.64	0.55	1.09	0.55	1.09	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.24	3.56	0.00	1.34	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	4.42	1.82	3.38	2.86	0.52	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	3.98	0.66	1.99	0.00	1.33	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	2.08	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.27	5.93	4.33	1.14	0.68	0.68	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	3.12	4.40	1.65	1.28	0.00	0.37	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.31	3.93	3.67	0.79	0.52	0.26	0.52	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.12	2.12	2.66	2.66	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	3.33	3.80	1.74	4.75	0.32	0.16	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	4.73	3.20	3.34	4.17	0.56	0.00	0.56	0.28
Mammary Epithelial Cell, donor1	11273-116H4	6.08	2.19	3.29	4.48	0.20	0.30	0.90	0.30
Mammary Epithelial Cell, donor2	11350-117G9	3.19	1.45	2.90	2.32	0.00	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	1.00	2.49	1.00	0.50	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	20.34	1.36	15.59	28.47	5.42	0.68	0.00	3.39
Mast cell, donor1	11563-120D6	20.11	5.62	7.89	3.78	2.38	3.14	1.95	0.32
Mast cell, donor2	11565-120D8	24.37	17.53	8.02	5.94	3.27	4.16	0.89	2.08
Mast cell, donor3	11566-120D9	23.64	18.91	7.65	7.65	6.30	4.95	0.68	1.80
Mast cell, donor4	11567-120E1	22.69	21.63	9.40	6.38	4.43	4.43	1.95	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	18.63	5.21	6.21	3.66	2.44	1.00	1.22	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	16.93	1.17	3.50	7.00	3.50	4.09	1.75	1.75
Mast cell, expanded, donor5	11939-126A4	12.73	2.75	5.05	1.26	2.75	1.26	0.69	0.69
Mast cell, expanded, donor8	11941-126A6	29.79	5.36	8.54	3.85	3.35	3.35	0.84	1.34
Melanocyte - dark, donor1	11502-119F8	2.98	2.09	2.98	1.69	0.30	0.40	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	4.50	1.04	1.38	0.69	0.00	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	7.39	2.25	2.75	1.59	0.58	0.29	0.00	0.14
Melanocyte - light, donor1	11274-116H5	4.00	0.71	1.18	0.47	1.65	0.71	0.24	0.00
Melanocyte - light, donor2	11351-117H1	4.09	0.68	0.00	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.87	0.87	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	5.73	1.67	3.54	0.62	0.62	0.10	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	2.42	1.34	1.34	1.88	0.27	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	9.91	4.55	4.29	1.87	0.27	0.54	0.27	0.00
Meningeal Cells, donor1	11493-119E8	3.10	1.98	1.12	0.87	0.74	0.12	0.37	0.00
Meningeal Cells, donor2	11573-120E7	3.96	1.76	1.76	0.44	0.00	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	4.89	2.36	1.87	1.30	0.90	0.24	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	2.85	2.85	4.56	1.71	2.28	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	6.54	2.62	3.72	1.91	1.01	0.81	0.91	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	3.59	1.44	0.72	1.44	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	4.66	3.39	1.69	1.27	1.06	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	0.00	2.51	1.51	0.00	0.50	0.50	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	0.44	2.64	0.66	0.22	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.19	0.00	0.73	0.00	0.73	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1.43	1.64	0.20	0.41	0.20	0.41	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.49	1.94	1.25	0.97	0.42	0.14	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.60	0.37	1.12	0.00	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6.18	1.97	2.63	2.50	0.53	1.05	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	1.19	0.00	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.92	1.92	1.28	0.00	0.64	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	3.90	1.06	2.84	0.35	0.71	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.00	2.19	4.38	2.81	0.00	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	0.73	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	2.12	3.71	3.71	2.12	0.27	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	4.00	6.51	3.50	0.50	0.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.42	4.55	2.10	1.66	0.43	0.22	0.29	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	13.50	0.00	1.35	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.85	5.91	2.96	2.71	0.25	0.00	0.49	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.18	4.71	3.83	1.47	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	10.37	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.58	1.86	2.17	1.86	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.11	2.90	2.28	0.62	0.21	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	2.32	0.00	0.00	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.76	2.00	2.00	1.00	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.31	8.38	3.26	0.93	0.47	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.05	2.85	3.86	0.81	0.00	0.41	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.17	5.15	2.38	1.58	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	25.65	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	0.88	0.88	3.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.28	2.28	3.04	1.14	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	5.26	1.32	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.03	2.76	1.49	0.64	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	3.68	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.58	2.68	2.98	0.60	0.30	0.30	0.30	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	6.71	0.00	0.00	0.00	1.68	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.76	2.76	2.76	1.51	0.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.14	3.09	1.90	0.95	0.24	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	3.32	1.11	0.00	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.99	1.15	0.69	1.61	0.23	0.00	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.89	2.31	1.68	1.26	0.42	0.21	0.21	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.06	3.06	1.22	1.43	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.36	1.93	1.50	0.86	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.67	6.00	1.56	0.44	0.22	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.94	2.19	1.10	0.44	0.00	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	7.60	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.97	4.62	1.63	0.54	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	2.94	1.47	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	6.54	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.96	0.96	0.48	0.96	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	4.00	0.80	2.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	8.23	0.00	1.37	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.00	0.00	1.50	0.50	0.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	2.63	0.44	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	5.52	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	7.68	2.56	0.64	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.47	2.48	0.00	0.50	0.50	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	4.18	0.00	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	13.26	0.00	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.42	2.05	1.03	0.00	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.94	3.94	1.31	0.00	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.88	8.52	1.78	0.00	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1.96	2.24	1.12	1.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.08	2.49	1.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	9.32	1.17	0.00	0.58	0.00	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.94	3.02	1.51	0.30	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.34	2.92	0.42	0.42	0.00	0.00	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	1.85	2.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.71	1.71	1.14	0.00	0.57	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.05	4.42	1.93	0.28	0.14	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.85	2.33	1.30	0.78	0.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.43	3.00	0.43	0.86	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.24	4.45	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.61	4.80	1.33	0.53	0.00	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.49	4.19	2.69	2.39	0.90	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.75	4.10	2.97	0.14	0.28	0.28	0.00	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.50	2.23	1.27	0.96	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.64	2.43	1.55	0.88	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.48	7.20	1.90	0.76	0.76	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.68	2.27	2.56	0.85	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.97	1.23	1.23	1.47	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.99	5.87	0.00	0.00	1.30	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	6.47	2.65	2.06	0.88	0.29	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.04	2.88	2.88	1.15	0.29	0.29	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.13	6.59	2.06	1.65	3.30	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.44	2.68	2.38	0.00	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.59	2.96	2.30	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	0.00	2.10	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.74	1.78	2.97	0.79	0.40	0.20	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	1.86	0.93	2.79	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.14	0.75	2.25	1.13	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.86	0.53	1.60	1.07	0.53	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.41	2.26	1.81	0.79	0.11	0.11	0.00	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.03	1.83	1.47	0.37	0.37	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	1.56	3.11	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.28	1.07	2.14	0.53	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	1.01	3.03	2.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.95	3.79	1.69	1.69	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	6.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.81	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	28.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	13.05	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.25	0.86	3.02	2.59	0.43	0.00	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.84	1.05	3.14	1.57	1.57	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	3.34	4.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.18	3.76	1.67	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	42.59	11.98	11.41	3.04	1.14	1.52	0.19	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	11.17	4.79	4.79	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	1.36	1.36	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	60.64	14.70	27.56	7.35	7.35	0.00	5.51	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	0.84	1.26	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.28	3.72	3.72	0.93	0.23	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.92	1.35	2.97	0.81	0.81	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	16.19	5.68	5.05	1.68	1.05	0.21	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	22.27	22.27	11.13	0.00	0.00	66.81	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	1.49	0.99	0.99	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.64	3.25	6.77	1.62	0.81	0.00	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.89	0.45	3.63	0.45	0.45	0.91	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.78	1.80	4.08	0.16	0.65	0.82	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.94	4.56	6.01	2.00	0.91	0.55	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	0.53	1.59	0.00	0.53	1.06	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	0.60	3.00	0.00	0.00	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	45.94	14.77	10.50	4.92	1.31	1.64	0.98	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.46	0.65	3.09	0.16	0.33	0.16	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.17	4.94	6.53	1.59	1.76	1.06	0.35	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	3.52	2.11	2.11	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	2.76	2.30	0.46	0.92	0.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.39	3.21	4.18	0.32	0.64	0.32	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.04	12.42	14.49	4.48	1.72	1.72	0.00	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	371.68	154.24	40.46	7.59	7.59	12.64	0.00	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.82	5.57	7.57	0.89	1.78	0.45	0.67	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	7.20	1.27	6.77	0.00	0.42	0.85	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.09	1.66	7.36	1.42	0.71	0.71	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.44	0.43	2.15	1.29	0.86	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	45.14	27.08	18.06	18.06	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.66	1.33	3.00	0.67	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	2.25	1.35	0.90	0.45	0.45	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.17	2.78	2.38	3.17	0.79	0.00	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	1.86	3.71	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.43	2.27	7.95	1.89	0.76	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.52	1.63	1.63	0.65	0.65	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	4.79	2.61	0.00	0.87	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	4.52	7.24	2.71	0.45	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	3.53	2.65	0.88	0.00	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	0.00	1.99	0.00	0.66	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	2.48	2.98	0.99	0.50	0.00	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	3.06	1.53	0.00	0.38	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.75	4.54	3.33	1.81	0.91	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.47	4.42	5.08	2.87	0.66	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	1.36	3.39	1.36	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	51.10	25.55	0.00	10.22	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	0.61	3.05	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.27	3.15	3.46	0.00	0.31	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.13	4.24	1.82	0.00	0.30	1.51	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	1.58	2.37	0.79	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	68.02	20.41	12.47	3.40	3.40	2.27	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	106.22	20.23	15.17	10.12	10.12	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	4.97	1.49	3.35	1.99	0.50	0.37	0.75	0.50
Myoblast, donor2	11322-117D8	13.04	5.18	4.79	1.73	0.38	0.19	0.38	0.58
Myoblast, donor3	11398-118D3	7.74	5.38	4.37	1.68	1.35	0.50	0.67	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	8.61	3.36	1.90	2.48	1.02	0.15	1.31	0.00
Natural Killer Cells, donor1	11230-116C6	58.12	7.07	15.68	11.07	7.69	2.15	2.77	2.46
Natural Killer Cells, donor2	11311-117C6	71.47	5.13	6.94	8.75	5.43	4.52	3.02	0.90
Natural Killer Cells, donor3	11387-118C1	72.15	10.49	14.36	11.23	5.71	4.05	2.58	0.74
Neural stem cells, donor1	11275-116H6	16.33	3.27	5.81	2.54	6.17	1.81	0.00	0.73
Neural stem cells, donor2	11352-117H2	19.26	0.00	3.85	1.93	13.48	3.85	0.00	1.93
Neurons, donor1	11494-119E9	12.52	0.00	6.83	0.00	4.55	3.41	0.00	0.00
Neurons, donor2	11574-120E8	6.60	2.20	3.30	2.42	4.40	1.54	0.00	0.22
Neurons, donor3	11655-122E8	13.15	0.82	2.47	0.82	4.11	3.29	0.82	0.82
Neutrophils, donor1	11233-116C9	18.56	77.95	12.99	16.70	5.57	4.64	0.93	3.71
Neutrophils, donor2	11314-117C9	26.09	60.88	8.70	26.09	2.90	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	21.38	128.28	25.66	29.93	12.83	12.83	0.00	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	8.55	3.68	3.92	1.42	1.42	0.47	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	3.58	1.30	1.95	0.65	0.00	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.41	2.01	2.81	0.60	1.20	0.20	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	11.84	0.28	5.92	1.65	0.83	0.55	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	11.43	1.30	4.78	3.91	0.72	0.14	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	9.65	2.84	5.22	2.27	0.57	0.11	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	18.12	1.95	6.72	3.21	1.07	0.19	0.68	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	6.62	4.81	4.21	4.81	1.81	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	1.91	2.13	0.00	0.21	0.64	0.00	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	3.43	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	0.62	1.24	0.62	1.86	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	1.76	0.59	0.78	0.00	0.39	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	2.11	1.40	2.81	1.40	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	6.04	2.31	3.55	0.53	1.07	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	6.32	3.54	4.63	1.94	1.43	0.42	0.25	0.08
Pericytes, donor1	11491-119E6	0.78	0.89	0.33	0.11	0.22	0.00	0.22	0.00
Pericytes, donor2	11571-120E5	2.04	0.91	0.68	0.00	0.45	0.00	0.23	0.45
Pericytes, donor3	11652-122E5	1.42	0.41	0.20	0.81	0.00	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	5.99	2.60	4.75	1.92	1.13	0.11	0.45	0.00
Perineurial Cells, donor2	11579-120F4	6.26	3.77	3.22	2.67	1.29	0.28	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	57.69	15.30	7.33	8.29	6.06	2.55	1.91	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	44.32	9.30	4.65	4.90	2.45	3.18	1.96	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	67.55	16.18	6.21	3.24	4.14	2.07	1.81	1.16
Placental Epithelial Cells, donor1	11278-116H9	1.43	4.30	0.72	0.24	0.48	0.48	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	0.00	1.11	1.11	2.22	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.94	1.96	0.98	0.59	0.20	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1.58	1.27	2.53	0.00	0.63	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	3.94	1.31	1.88	1.69	0.94	0.19	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.22	6.92	6.27	4.18	1.70	0.13	1.31	0.26
Preadipocyte - breast, donor2	11328-117E5	4.95	2.25	2.93	0.45	1.35	0.45	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	8.31	2.77	3.41	1.60	1.28	0.53	0.21	0.32
Preadipocyte - omental, donor2	11329-117E6	6.98	2.62	0.87	1.31	0.87	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	8.45	3.29	4.01	2.44	0.86	0.57	0.57	0.43
Preadipocyte - perirenal, donor1	11469-119C2	0.98	0.00	0.00	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	1.23	3.69	0.00	0.31	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	3.72	3.19	3.19	0.71	0.00	0.00	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	3.75	2.89	1.02	1.36	0.34	0.00	0.17	0.34
Preadipocyte - visceral, donor1	11280-116I2	5.50	4.28	3.73	1.68	0.93	0.28	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	3.22	3.22	0.00	1.38	0.92	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	1.88	1.67	1.99	0.73	0.52	0.10	0.21	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	4.83	3.92	5.58	13.58	3.02	0.45	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	3.79	2.71	1.76	0.95	0.54	0.41	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	5.57	5.45	1.47	3.06	0.92	0.61	0.31	0.12
Prostate Stromal Cells, donor1	11254-116F3	2.62	2.05	2.39	2.28	0.57	0.23	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	2.51	2.51	0.90	2.15	0.18	0.36	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	4.28	2.82	2.61	1.46	0.73	0.73	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.92	1.09	0.73	0.00	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	3.19	2.43	2.22	1.87	0.69	0.14	0.07	0.14
Renal Epithelial Cells, donor1	11517-119H5	1.01	2.03	0.00	0.51	0.51	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	4.98	2.33	1.59	2.65	0.74	0.21	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1.35	1.21	0.40	0.67	0.27	0.13	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.10	4.44	4.00	2.66	0.22	0.22	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	1.33	2.00	0.67	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	2.20	1.10	0.88	0.22	0.44	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	1.88	1.25	1.25	1.25	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.66	0.55	0.00	0.28	0.83	0.00	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	1.61	1.88	0.54	0.81	0.27	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	0.42	0.42	0.00	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1.74	1.74	0.77	0.58	0.39	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	4.15	2.33	3.37	1.56	1.04	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	2.27	0.85	0.28	1.42	0.28	0.28	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	1.03	1.03	2.06	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2.76	0.75	0.75	0.75	1.51	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	14.30	14.43	5.48	4.41	2.14	1.20	1.07	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	32.16	1.79	1.79	1.79	1.79	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	25.87	1.65	2.75	8.81	3.30	3.85	1.10	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	42.92	5.22	10.44	2.90	7.54	3.48	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.74	4.16	5.98	6.11	5.72	1.82	1.69	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	18.27	3.48	7.35	3.48	2.98	1.39	0.50	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	18.40	3.35	9.15	5.02	5.24	1.90	1.78	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.68	4.22	7.81	6.57	6.33	1.98	1.24	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.40	5.13	6.64	3.15	3.03	0.93	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	21.26	3.70	9.25	6.47	5.08	2.31	1.62	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.91	5.07	6.02	1.78	4.38	2.33	0.68	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	15.58	5.29	6.20	3.63	4.54	1.36	0.76	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.64	6.27	8.06	2.87	5.91	1.43	1.79	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	9.32	4.02	4.16	1.86	4.16	2.44	1.00	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	11.80	2.90	6.98	2.68	3.00	1.93	0.75	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.90	2.88	7.08	2.88	4.20	1.99	2.43	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.97	3.06	6.88	4.97	4.59	1.15	0.19	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.61	5.59	7.55	2.14	2.98	2.52	0.19	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.41	4.51	8.46	4.32	6.20	2.63	1.88	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.74	5.71	6.77	2.92	6.77	1.59	1.06	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.32	6.33	9.15	3.31	4.48	2.04	0.88	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.87	3.44	8.98	3.63	6.68	2.10	2.10	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	11.96	6.94	5.13	3.42	3.84	1.50	0.11	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.14	3.92	3.92	2.52	2.80	1.68	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.75	6.15	7.86	2.56	4.27	1.03	0.51	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.76	6.38	5.83	3.10	4.74	0.91	0.73	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.50	3.31	7.36	2.45	3.43	1.10	0.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.18	5.64	7.66	3.36	6.18	3.09	2.28	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.91	4.25	4.01	2.12	2.83	0.47	1.65	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.86	4.56	6.94	1.59	2.78	1.98	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.72	5.14	6.08	1.87	6.78	2.57	1.64	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.44	4.56	5.60	3.53	3.11	0.83	0.83	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.02	4.65	4.42	3.54	5.09	2.65	0.88	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	28.41	4.39	8.36	3.34	3.97	1.46	1.67	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.71	4.58	4.17	2.96	3.36	0.81	0.94	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.02	6.47	7.83	1.70	4.43	2.38	0.34	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	28.53	6.36	10.60	3.28	3.66	2.12	1.35	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.69	6.02	2.75	3.61	2.58	0.86	1.38	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.43	4.66	7.54	3.02	5.08	2.61	0.27	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.09	6.73	7.55	4.43	4.60	1.64	1.48	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.08	5.62	4.60	2.90	3.41	0.85	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	19.09	4.73	6.07	2.81	4.44	2.07	1.33	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.59	9.06	9.60	2.13	3.20	1.07	0.53	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.92	4.01	3.46	2.90	5.39	2.07	0.97	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.05	3.10	5.24	1.67	5.00	1.43	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	45.95	6.85	9.88	3.43	6.25	3.22	1.21	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.66	1.98	4.61	1.79	4.14	0.94	0.66	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	21.31	4.19	9.43	2.10	5.59	1.05	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.01	4.53	6.04	2.42	4.23	1.21	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	11.01	4.65	4.65	1.96	3.30	1.96	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	71.03	10.33	20.52	10.92	15.43	5.97	3.78	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	19.47	2.43	9.73	6.08	4.87	3.65	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.06	4.52	4.22	1.81	3.62	0.60	0.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.49	5.20	4.98	2.49	3.17	4.07	0.90	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	33.55	6.29	11.68	3.00	8.99	3.00	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.44	6.26	4.25	3.31	6.14	1.06	0.94	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.91	4.48	7.68	4.48	6.40	4.27	1.92	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.85	5.41	6.61	2.40	7.21	1.80	1.20	2.40
Schwann Cells, donor1	11498-119F4	1.32	0.38	0.38	0.00	0.38	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	5.70	1.31	2.19	0.88	0.00	0.00	0.22	0.00
Sebocyte, donor1	11220-116B5	2.19	1.64	0.00	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	4.14	3.22	0.92	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	1.65	1.65	0.41	0.00	0.00	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	4.97	3.31	4.97	4.97	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	0.00	0.00	0.00	0.00	2.82	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	5.81	3.70	3.87	1.14	1.50	0.44	0.18	0.09
Skeletal Muscle Cells, donor2	11358-117H8	0.72	2.17	0.72	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	1.67	1.67	1.67	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	4.08	3.30	2.04	1.10	0.47	0.16	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	2.82	3.86	1.34	0.30	0.59	0.00	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	3.69	6.46	2.77	1.08	1.23	0.46	0.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	7.56	8.19	7.06	2.65	1.01	0.63	0.63	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.13	5.14	3.28	1.85	1.14	0.29	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	7.94	7.64	6.65	1.49	0.69	0.50	0.50	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.33	1.94	2.61	2.02	0.59	0.34	0.17	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	1.45	2.17	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1.51	2.20	0.55	0.14	0.14	0.14	0.14	0.28
Skin - palm, donor1	10286-104F7	26.86	8.06	13.43	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1.30	1.87	0.43	0.29	0.43	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.90	31.90	5.73	9.00	0.82	0.00	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.99	1.82	0.13	0.13	0.13	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	3.06	1.53	2.50	2.78	0.56	0.14	0.00	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	9.99	4.50	1.97	2.25	0.28	0.98	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	28.97	34.25	10.57	17.13	1.90	0.85	4.23	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	10.57	6.07	2.77	1.35	0.75	0.67	0.15	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.54	3.09	1.23	1.23	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.11	10.23	3.78	6.45	1.11	0.67	0.67	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	1.76	2.35	2.94	0.59	0.00	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	2.87	1.33	0.88	0.44	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	0.39	1.97	0.39	0.00	0.39	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	2.32	3.09	0.77	1.55	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	2.00	2.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.00	1.20	0.53	0.40	0.13	0.00	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	6.65	1.77	0.89	0.44	0.44	0.44	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	3.33	4.74	2.82	1.28	1.41	0.38	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.16	0.98	5.54	1.63	1.30	0.33	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	9.16	3.84	4.13	2.95	1.48	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.69	3.42	4.56	1.99	0.85	0.57	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	0.65	0.81	0.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	2.74	3.35	1.83	0.00	0.91	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	1.26	0.76	1.26	0.00	0.51	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1.91	1.91	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	3.83	2.51	3.10	2.51	1.92	0.44	0.88	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	6.46	4.52	2.37	1.94	0.86	0.00	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	5.67	4.30	4.72	2.52	0.63	0.42	0.31	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1.55	0.46	0.31	0.62	0.15	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	2.16	0.00	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	1.20	2.39	0.60	0.60	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1.71	1.37	0.00	0.00	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	4.71	3.46	3.61	3.46	0.71	0.47	0.55	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	7.95	3.52	3.93	1.01	2.92	1.01	0.30	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	4.32	3.64	2.28	1.37	0.23	0.00	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	0.00	1.81	0.60	0.00	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	3.71	3.97	2.91	2.38	0.79	0.53	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	2.93	3.86	1.86	2.13	0.80	0.00	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.89	3.26	3.13	2.25	1.25	0.88	0.38	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	2.54	6.09	0.51	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	5.58	4.07	2.71	2.11	0.75	0.15	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	2.25	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	0.00	2.58	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	3.72	3.26	1.86	0.47	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.52	3.53	0.50	0.50	0.00	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	2.51	1.25	0.31	0.31	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.88	0.59	0.00	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	5.33	4.50	3.92	1.50	0.58	0.33	0.17	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.94	3.74	2.34	0.00	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1.30	1.44	1.01	0.29	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3.57	2.55	1.53	0.51	0.00	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	0.38	0.75	0.38	0.19	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	4.47	5.59	2.24	1.40	0.84	0.28	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.94	2.09	2.26	1.26	0.50	0.17	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.95	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	0.24	0.98	1.22	0.00	0.24	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3.54	2.43	1.99	1.10	0.00	0.66	1.33	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	2.63	1.17	4.68	1.46	0.29	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.19	2.33	1.94	0.97	0.78	0.00	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.55	0.79	2.38	2.38	0.53	0.26	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.23	2.23	2.23	3.72	0.00	0.37	1.49	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.03	1.80	2.52	2.52	0.36	0.00	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.56	1.14	3.41	1.14	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	3.94	0.79	0.00	0.79	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	4.57	3.56	2.29	1.78	1.27	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	7.19	4.39	3.19	1.20	0.40	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	3.76	1.67	0.84	1.67	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	3.67	2.29	2.75	1.38	0.46	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	7.07	1.85	3.20	0.67	1.68	0.50	0.17	0.17
Synoviocyte, donor2	11368-117I9	8.05	2.85	2.01	0.50	0.67	0.50	0.00	0.50
Synoviocyte, donor3	11440-118H9	3.57	2.46	2.01	1.34	0.22	0.67	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	2.86	2.14	0.00	0.36	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	2.78	1.39	1.16	1.16	0.46	0.00	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	2.51	2.08	1.00	0.79	0.14	0.00	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	2.32	0.39	1.93	0.00	0.39	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	0.57	2.29	0.00	0.00	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.06	14.52	4.06	2.83	2.34	0.86	2.46	0.98
Urethra, donor2	10319-105A4	82.73	10.79	10.79	5.40	5.40	1.80	1.80	3.60
Urothelial Cells, donor1	11520-119H8	0.53	0.27	0.27	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	1.15	1.38	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	2.90	4.24	1.78	2.01	0.22	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	20.47	6.23	3.56	7.12	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	18.58	0.00	7.15	7.15	0.00	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.17	12.32	5.48	3.42	3.42	1.37	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.20	14.81	4.48	6.54	5.17	0.34	0.69	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.94	12.20	4.07	3.49	2.91	0.58	2.32	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	15.62	0.00	3.12	2.08	1.04	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	13.77	19.27	1.84	4.59	6.42	0.00	3.67	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	27.39	13.69	4.56	3.65	2.74	0.91	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	6.78	1.11	6.91	14.43	1.36	0.62	1.60	0.25
Wilms' tumor cell line:HFWT	10597-108E3	6.16	9.68	3.52	2.64	1.76	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.41	5.87	5.03	1.96	1.68	0.00	1.12	0.84
achilles tendon, donor2	10292-104G4	20.67	0.00	6.20	4.13	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	7.39	4.08	4.33	1.27	0.76	1.78	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	17.41	10.45	2.79	1.39	2.32	0.70	0.93	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.79	6.41	8.31	9.73	5.94	2.14	3.68	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	12.25	7.35	5.44	4.35	2.18	1.09	1.63	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.96	1.97	6.18	6.75	0.84	0.84	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	13.32	5.29	2.75	2.11	3.17	1.48	0.63	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.14	9.26	1.91	4.08	1.09	1.09	2.99	2.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	12.78	5.73	3.53	2.64	2.20	0.44	1.76	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	18.38	4.49	3.68	3.68	1.63	0.82	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	35.72	7.77	3.88	1.16	0.78	0.78	1.94	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.36	1.66	1.47	2.02	1.66	0.18	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	11.70	15.60	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.78	3.02	6.97	6.27	1.39	0.70	1.86	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	4.14	2.33	1.29	0.26	0.52	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.66	3.80	3.21	1.17	0.29	0.88	0.58	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.89	2.79	3.72	0.93	0.00	1.86	1.86	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.93	5.35	1.65	0.00	0.82	0.41	2.06	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	15.35	0.61	1.23	0.61	0.31	0.61	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	15.36	2.56	5.97	2.13	0.85	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	12.74	2.43	9.10	0.91	0.91	0.30	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	12.28	5.54	3.85	1.93	1.93	0.24	0.96	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	9.13	3.56	2.23	2.00	0.45	0.22	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.01	2.33	5.34	4.67	0.00	0.33	1.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	14.87	1.86	14.87	3.72	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.18	6.03	3.77	4.52	1.13	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.07	6.98	7.41	2.62	3.05	5.23	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	31.87	7.50	0.00	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	27.32	2.12	5.89	4.24	0.47	0.71	0.24	0.94
adipose tissue, adult, pool1	10010-101C1	8.84	11.01	4.81	1.24	3.57	0.93	0.47	1.24
adipose, donor1	10184-103D4	16.42	16.42	21.70	34.60	5.28	5.28	1.76	0.59
adipose, donor2	10185-103D5	8.11	1.62	1.62	5.27	1.22	0.81	2.03	0.00
adipose, donor3	10186-103D6	16.88	2.18	4.36	9.80	2.45	1.63	1.09	0.00
adipose, donor4	10187-103D7	56.34	0.00	4.33	12.13	0.87	3.47	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.68	19.25	9.47	2.84	2.21	1.26	0.79	0.63
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	3.64	0.00	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	19.48	3.34	7.74	2.93	1.60	1.07	1.07	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.79	3.22	6.79	4.64	1.43	1.07	2.86	0.36
amniotic membrane cells, donor1	12235-129G3	13.22	9.74	5.33	2.32	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	9.47	6.09	4.06	4.73	0.34	1.01	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	10.61	7.95	3.54	1.77	0.29	0.00	0.29	0.59
amygdala - adult, donor10196	10167-103B5	27.27	7.11	2.37	3.56	1.19	0.00	1.19	2.37
amygdala, adult, donor10252	10151-102I7	59.61	19.06	8.72	4.06	3.04	3.04	0.81	4.06
amygdala, newborn, donor10223	10360-105E9	14.52	1.61	1.61	3.87	1.29	1.29	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	8.02	8.40	2.93	1.27	1.53	0.89	0.51	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.35	5.74	3.53	3.31	0.00	0.22	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	26.39	6.35	20.71	19.04	9.02	2.34	8.35	1.00
aorta, adult, pool1	10052-101G7	18.63	4.71	5.10	3.14	1.37	0.20	0.98	0.98
appendix, adult	10189-103D9	59.77	29.11	11.26	9.31	7.37	4.66	3.49	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	11.69	6.88	2.06	2.41	0.69	1.38	4.47	0.00
artery, adult	10190-103E1	8.15	4.08	6.79	1.36	2.72	1.36	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	12.89	4.78	5.79	6.66	3.62	1.01	1.01	0.14
b cell line:RPMI1788	10427-106D4	11.00	8.48	5.06	5.50	2.83	0.89	1.19	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	5.55	4.44	4.44	2.22	0.83	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.30	6.85	2.08	1.89	0.99	0.69	0.79	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	6.70	6.70	1.51	3.18	0.67	1.00	1.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.98	0.56	1.12	0.56	1.68	1.68	1.12	0.00
bladder, adult, pool1	10011-101C2	14.67	11.52	6.30	5.11	3.37	1.63	1.09	1.09
blood, adult, pool1	10053-101G8	22.15	2.21	8.86	0.00	4.43	6.64	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	10.28	1.71	2.57	1.71	0.00	0.00	0.86
bone marrow, adult	10192-103E3	6.07	2.02	1.35	2.70	1.35	0.67	1.35	1.35
brain, adult, donor1	10084-102B3	23.58	2.05	3.08	3.08	0.00	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	17.82	7.46	4.79	2.56	3.01	1.34	1.22	0.45
brain, fetal, pool1	10085-102B4	16.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	36.01	8.26	3.30	1.65	1.98	1.65	0.33	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	32.33	8.74	3.12	4.12	1.62	0.50	0.87	0.62
breast, adult, donor1	10080-102A8	12.00	6.94	3.16	1.26	0.00	4.42	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.50	1.65	1.52	2.54	0.51	0.00	0.76	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	21.03	5.88	3.40	4.33	0.00	0.93	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.30	6.22	6.68	8.75	0.69	0.00	3.68	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	5.33	4.36	1.94	2.18	0.00	0.73	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	5.17	5.17	4.23	1.88	3.29	0.47	2.35	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.38	8.75	3.50	1.97	1.09	1.09	0.22	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	6.02	3.49	4.44	1.90	1.90	0.00	1.58	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	17.30	5.32	2.93	1.33	2.40	1.06	1.86	0.00
caudate nucleus - adult, donor10196	10177-103C6	33.39	5.76	8.06	8.06	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	47.19	11.38	4.69	3.68	2.18	1.84	1.67	1.34
caudate nucleus, adult, donor10258	10379-105H1	19.10	3.82	4.58	1.53	3.82	2.29	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	21.97	2.56	6.23	1.83	3.66	2.56	0.37	1.83
cerebellum - adult, donor10196	10173-103C2	171.88	8.74	20.39	20.39	11.65	2.91	8.74	2.91
cerebellum, adult, donor10252	10166-103B4	217.78	16.87	12.38	11.53	9.61	10.03	4.06	7.90
cerebellum, adult, pool1	10083-102B2	51.74	3.10	3.45	3.79	3.45	4.48	1.38	1.72
cerebellum, newborn, donor10223	10357-105E6	57.29	5.81	5.81	13.28	5.81	3.32	0.83	0.83
cerebral meninges, adult	10188-103D8	22.44	6.56	2.77	1.26	4.54	1.01	0.25	1.51
cerebrospinal fluid, donor2	10294-104G6	19.00	2.92	0.00	1.46	3.65	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.08	6.18	3.02	2.44	1.15	0.58	0.72	0.14
cervical cancer cell line:ME-180	10553-107I4	11.10	2.65	5.30	3.31	0.83	0.33	1.33	0.50
cervix, adult, pool1	10013-101C4	22.36	17.53	6.09	5.14	5.67	3.46	1.78	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	5.85	4.60	5.43	3.34	1.53	0.56	1.25	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	14.37	5.23	0.00	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	5.10	12.05	3.36	2.98	3.36	1.12	1.86	0.12
choriocarcinoma cell line:SCH	10785-110H2	4.31	9.12	4.81	5.67	1.36	0.12	1.23	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	5.46	19.69	2.37	2.85	0.47	0.47	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	5.13	8.83	2.28	1.71	0.00	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	5.27	8.05	5.57	3.78	2.29	0.80	0.00	0.20
chorionic membrane cells, donor3	12240-129G8	4.40	8.24	1.65	2.75	0.55	1.65	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	3.03	0.00	3.03	0.00	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	17.87	3.27	5.96	1.73	0.96	0.58	1.34	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	26.40	4.65	4.43	2.32	0.21	0.63	1.90	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.50	3.34	4.11	10.27	0.77	1.80	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	11.85	4.60	6.29	8.95	0.48	0.24	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	13.03	5.09	4.68	9.37	0.61	0.41	0.41	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	10.31	9.13	9.42	17.96	0.59	0.29	3.83	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	32.58	9.12	5.73	5.21	3.39	0.52	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	3.20	3.66	1.14	1.60	1.83	0.46	0.69	0.46
clear cell carcinoma cell line:TEN	10636-108I6	8.85	7.98	3.64	2.78	0.69	0.00	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	6.22	1.83	10.98	10.62	1.65	0.18	0.92	0.18
colon carcinoma cell line:COLO-320	10420-106C6	28.89	3.04	12.54	11.02	4.18	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	24.99	5.95	3.57	2.38	1.19	0.00	1.19	1.19
colon, adult, pool1	10014-101C5	19.04	13.28	6.23	7.29	3.29	1.41	0.94	0.59
colon, fetal, donor1	10070-101I7	34.61	3.71	6.80	3.09	1.85	3.09	2.47	0.62
common myeloid progenitor CMP, donor1	12130-128D6	119.17	64.17	13.75	13.75	18.33	13.75	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.62	10.62	4.25	7.22	1.70	1.70	2.97	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.11	5.89	2.57	3.77	1.36	1.21	1.06	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	11.42	6.63	4.79	5.50	1.55	1.13	0.99	0.56
corpus callosum, adult, pool1	10042-101F6	23.00	11.94	7.08	3.87	3.10	1.55	1.33	1.11
cruciate ligament, donor2	10295-104G7	29.99	8.92	8.92	1.62	0.81	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	6.42	5.62	0.80	2.41	0.00	0.00	0.00
diencephalon, adult	10193-103E4	18.48	2.88	2.40	2.88	1.20	0.72	0.96	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	8.73	5.97	3.21	6.89	1.61	0.23	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.26	14.87	3.59	3.59	3.08	1.03	2.05	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.26	1.69	7.22	7.22	1.69	0.48	0.72	0.48
ductus deferens, adult	10196-103E7	40.37	8.97	8.97	6.48	3.49	2.99	2.99	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	2.88	4.32	4.32	1.44	0.00	8.64	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	29.43	7.36	4.41	11.03	1.47	1.47	2.94	0.74
dura mater, adult, donor1	10041-101F5	22.22	9.25	8.84	5.37	2.40	2.15	1.07	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.66	2.44	7.11	8.44	5.11	1.55	0.67	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	4.73	2.01	4.44	7.31	1.58	0.29	1.15	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	18.50	14.80	1.85	0.62	0.62	0.62	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	8.17	9.38	1.21	2.42	0.91	0.91	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	18.83	20.69	3.40	2.47	1.23	0.93	0.31	0.93
embryonic pancreas cell line:2C6	10603-108E9	21.02	15.76	1.31	1.31	2.63	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	7.04	4.69	8.38	5.70	3.02	0.00	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	7.07	6.89	6.52	3.81	1.27	0.18	0.72	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1.93	4.34	1.61	2.57	0.32	0.00	0.80	0.32
epidermoid carcinoma cell line:A431	10426-106D3	14.45	6.45	3.22	3.11	0.89	0.33	0.89	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	14.52	9.02	2.86	4.51	1.32	1.21	1.98	0.33
epididymis, adult	10197-103E8	31.61	11.72	5.86	3.98	5.65	2.93	1.88	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	10.47	3.19	2.31	2.13	1.42	0.53	0.18	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.08	1.97	2.36	3.93	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.89	7.99	3.01	1.97	0.26	0.26	0.92	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.91	6.79	4.53	2.36	0.30	0.59	0.30	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	15.57	6.95	4.03	2.35	1.12	0.45	1.12	0.34
esophagus, adult, pool1	10015-101C6	11.47	9.87	4.25	3.93	2.02	1.06	0.53	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	17.16	14.28	8.52	15.78	2.50	0.75	1.75	2.25
eye - muscle inferior rectus, donor1	10272-104E2	24.15	7.24	4.83	7.24	2.41	0.00	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	37.88	4.21	4.21	0.00	0.00	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	40.18	4.46	2.98	1.49	1.49	0.00	0.00	4.46
eye - muscle superior, donor2	10297-104G9	29.81	9.17	4.59	4.59	1.15	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	2.91	7.29	7.29	2.91	5.83	0.00	1.46
eye, fetal, donor1	10054-101G9	20.85	4.32	2.80	4.83	1.53	0.51	0.51	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	9.49	6.80	2.18	1.15	0.64	0.38	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.92	7.83	4.04	2.14	0.95	0.24	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	32.74	7.98	6.10	3.66	3.38	2.25	0.94	1.50
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	33.33	12.01	4.20	8.71	1.50	0.60	2.70	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	4.48	14.08	3.84	3.84	1.19	0.37	1.01	0.09
gall bladder, adult	10198-103E9	28.25	8.45	4.83	2.41	1.45	1.45	0.97	0.97
gamma delta positive T cells, donor1	11937-126A2	38.65	4.83	6.44	5.91	4.83	1.07	1.07	1.07
gamma delta positive T cells, donor2	11938-126A3	33.99	2.61	4.86	4.11	2.99	2.24	0.37	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.25	2.32	2.32	3.17	0.42	0.21	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	15.09	7.54	4.64	6.96	1.35	0.58	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	6.72	6.56	14.59	11.15	1.97	0.33	1.64	0.33
gastric cancer cell line:GSS	10560-108A2	4.58	8.24	2.75	3.66	0.92	1.83	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.16	4.80	5.71	7.08	5.03	2.74	2.51	0.23
giant cell carcinoma cell line:LU65	10487-107B1	1.38	6.65	0.92	0.92	0.00	0.00	0.69	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	31.21	10.22	18.47	25.05	4.90	1.40	2.66	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.71	5.49	4.24	0.75	0.50	0.75	0.25	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.98	6.12	8.97	2.85	2.32	0.11	0.95	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.55	6.18	10.11	2.81	2.39	0.42	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	5.63	2.54	4.64	2.76	0.99	0.22	0.44	0.00
glioma cell line:GI-1	10413-106B8	5.86	5.27	9.66	7.61	2.34	0.00	1.46	0.00
globus pallidus - adult, donor10196	10175-103C4	34.26	2.92	5.10	0.73	1.46	1.46	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	45.65	20.02	11.47	8.79	4.15	3.66	2.93	1.46
globus pallidus, adult, donor10258	10367-105F7	15.06	4.11	5.48	0.00	0.00	0.00	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	13.86	3.73	2.66	0.53	2.13	2.13	1.07	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	166.41	39.15	2.45	4.89	9.79	14.68	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.60	3.84	2.56	1.60	0.96	0.32	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	3.21	0.92	3.21	4.13	1.38	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	6.40	0.91	3.66	6.86	0.46	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	5.15	1.29	1.29	4.51	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	0.00	1.44	4.31	2.87	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	5.49	1.37	0.00	6.17	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	11.03	2.21	2.21	3.31	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	8.05	5.46	2.30	2.59	0.86	0.29	1.44	0.29
heart - mitral valve, adult	10205-103F7	20.63	6.88	8.67	1.79	2.09	2.39	1.79	1.79
heart - pulmonic valve, adult	10206-103F8	24.58	10.98	7.58	3.14	2.09	2.61	2.35	0.52
heart - tricuspid valve, adult	10207-103F9	26.64	30.81	7.49	6.66	5.00	0.83	2.50	6.66
heart, adult, diseased post-infarction, donor1	10050-101G5	9.39	4.08	2.86	2.04	1.02	0.41	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	14.05	3.83	1.28	1.70	0.85	0.85	0.00	0.85
heart, adult, pool1	10016-101C7	9.89	12.88	3.22	0.00	1.61	0.23	0.00	0.92
heart, fetal, pool1	10046-101G1	23.62	16.33	6.37	5.13	5.24	1.13	1.03	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	14.81	7.71	3.70	1.54	1.54	0.00	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	24.97	2.38	4.76	3.57	2.38	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.22	4.31	10.06	12.71	2.32	0.55	1.33	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	15.29	6.55	10.44	16.63	2.91	1.34	0.36	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.72	7.38	10.11	19.10	2.12	1.41	0.61	0.51
hepatoma cell line:Li-7	10484-107A7	5.12	2.34	4.00	9.56	1.89	0.22	1.45	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.55	2.11	3.12	2.61	0.50	1.11	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	32.18	2.84	5.68	1.89	2.84	1.89	0.95	2.84
hippocampus, adult, donor10252	10153-102I9	60.41	16.12	11.43	7.96	3.06	4.29	1.02	2.45
hippocampus, adult, donor10258	10374-105G5	12.95	3.98	0.00	1.99	1.99	0.00	0.50	1.99
hippocampus, newborn, donor10223	10363-105F3	21.85	2.82	1.76	1.76	2.47	2.11	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.05	3.05	7.93	8.54	3.05	1.22	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.28	2.95	3.14	5.11	1.96	0.59	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	7.62	4.32	5.08	3.55	6.35	0.25	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	2.26	2.82	6.77	1.13	0.56	2.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	12.65	3.87	6.46	8.78	4.13	2.07	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.83	4.18	4.56	8.35	4.18	1.14	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.76	2.63	4.38	9.63	5.55	1.46	2.04	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.48	2.37	5.82	9.05	3.45	0.65	0.86	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.84	0.83	4.17	4.17	2.92	0.83	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.81	3.32	3.55	4.97	3.08	0.95	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	7.23	1.77	3.54	3.05	3.05	0.96	0.80	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	1.35	4.04	6.73	4.04	2.69	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.89	3.13	4.23	3.76	3.44	0.94	0.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.86	1.47	2.46	8.35	0.98	0.00	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	2.62	1.75	3.49	12.22	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	14.13	7.06	5.92	9.35	2.86	1.34	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	14.39	3.92	4.36	11.34	2.62	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.49	2.00	9.00	15.99	3.00	3.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.84	1.32	3.96	9.98	2.45	0.75	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.64	0.91	2.73	14.55	2.73	0.91	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.01	0.31	0.63	6.89	2.82	1.57	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.17	2.45	2.94	6.37	1.96	1.63	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.39	2.03	2.32	8.13	2.90	1.16	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.67	1.49	2.39	4.18	5.38	2.09	0.90	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.25	2.59	4.80	3.88	2.22	0.74	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.14	3.99	3.14	3.99	2.00	0.57	1.43	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.31	4.08	4.08	5.31	2.45	0.41	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.10	3.17	5.99	12.67	1.41	1.06	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	8.87	1.58	3.48	6.97	1.27	2.22	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	8.47	1.51	3.63	5.14	3.03	1.51	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	3.10	3.62	4.14	8.79	1.03	0.52	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	5.31	1.99	2.66	7.31	1.99	0.66	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.39	0.77	1.80	7.95	2.82	0.51	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	5.88	1.79	2.81	5.62	1.53	2.05	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	11.36	1.51	1.51	6.82	2.27	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.07	1.01	2.02	4.70	1.68	1.01	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.35	3.14	2.17	4.83	2.17	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	5.79	0.89	3.12	5.79	2.67	0.00	1.78	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	3.41	0.98	3.41	9.27	2.44	1.46	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	10.09	3.06	3.97	12.22	3.36	0.92	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	16.27	26.03	143.14	13.01	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.27	2.98	6.29	11.91	3.31	1.65	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	4.93	0.55	4.93	9.85	1.64	0.55	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	4.70	0.72	5.07	4.34	2.17	1.45	1.09	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.05	1.78	3.56	7.12	0.36	0.36	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	1.19	2.39	4.77	2.39	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	6.64	2.44	5.42	8.13	5.01	0.68	1.08	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.27	0.54	3.23	6.73	2.69	2.16	1.08	0.27
immature langerhans cells, donor1	11904-125F5	15.26	11.87	3.87	3.87	0.73	0.24	0.24	0.24
immature langerhans cells, donor2	11905-125F6	19.80	11.88	10.30	7.13	1.58	0.00	2.38	0.79
insula, adult, pool1	10039-101F3	28.77	7.57	3.12	2.84	4.07	1.99	1.99	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	4.88	2.28	1.95	0.65	0.33	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	14.32	10.81	5.41	2.90	1.00	1.10	0.80	0.60
kidney, fetal, pool1	10045-101F9	21.57	10.75	2.83	2.97	3.82	0.85	0.28	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	15.76	13.92	3.12	1.99	2.41	0.71	0.99	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.29	4.15	2.90	2.49	0.28	0.41	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	7.52	6.79	2.57	2.39	1.28	0.55	0.37	0.00
left atrium, adult, donor1	10079-102A7	16.35	2.72	2.18	2.18	1.09	0.54	0.54	0.54
left ventricle, adult, donor1	10078-102A6	5.06	2.53	1.01	0.51	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	16.42	9.58	8.48	6.02	0.55	1.09	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	1.44	0.72	0.00	1.08	0.72	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	1.63	1.09	0.54	1.09	0.00	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	2.43	1.46	0.49	0.49	0.24	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	6.27	1.05	2.09	2.09	0.00	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	13.10	7.20	4.60	2.83	1.65	1.42	1.77	0.47
liposarcoma cell line:KMLS-1	10782-110G8	11.40	4.69	6.87	3.59	1.56	0.16	1.41	0.00
liposarcoma cell line:SW 872	10726-110A6	15.96	2.68	3.53	1.95	0.97	0.24	0.00	0.00
liver, adult, pool1	10018-101C9	10.53	8.27	2.59	2.11	1.13	1.13	0.00	0.49
liver, fetal, pool1	10086-102B5	6.58	3.76	2.82	2.82	0.94	1.88	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	32.08	8.17	8.17	4.67	3.79	2.04	1.60	1.75
locus coeruleus, adult, donor10252	10165-103B3	36.17	15.13	8.67	3.88	2.21	1.48	2.40	1.48
locus coeruleus, adult, donor10258	10375-105G6	9.31	3.67	1.69	2.26	2.26	1.13	1.13	0.85
locus coeruleus, newborn, donor10223	10362-105F2	25.24	7.15	6.73	5.47	5.89	1.26	0.00	1.26
lung adenocarcinoma cell line:A549	10499-107C4	7.33	7.75	4.98	5.67	0.97	0.14	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	11.72	25.51	4.83	3.45	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	24.52	5.54	4.35	2.24	1.05	0.66	0.26	0.26
lung, adult, pool1	10019-101D1	17.13	16.89	7.56	6.02	3.43	1.06	0.35	0.35
lung, fetal, donor1	10068-101I5	24.83	18.84	8.56	14.56	5.42	1.43	7.99	2.85
lung, right lower lobe, adult, donor1	10075-102A3	43.53	10.08	8.71	5.04	5.96	6.87	2.75	0.46
lymph node, adult, donor1	10077-102A5	34.08	10.41	6.15	3.31	2.84	3.79	0.00	2.37
lymphangiectasia cell line:DS-1	10727-110A7	12.71	9.21	1.75	0.66	0.22	0.66	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	52.22	46.49	39.84	47.39	22.04	5.58	10.72	5.13
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	15.29	21.24	3.40	5.95	1.70	0.00	1.70	1.70
mature adipocyte, donor1	12231-129F8	13.32	21.31	6.22	2.22	1.78	0.89	0.00	0.89
mature adipocyte, donor2	12232-129F9	14.32	12.87	8.30	3.32	2.08	1.04	0.00	0.00
mature adipocyte, donor3	12233-129G1	10.67	16.36	5.93	2.13	0.71	0.71	0.47	0.95
mature adipocyte, donor4	12234-129G2	7.90	12.90	9.21	2.90	2.11	1.58	0.79	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.88	25.02	7.39	5.24	3.34	1.67	1.19	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	5.64	5.64	3.38	2.26	0.00	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	62.16	13.98	5.70	4.78	3.49	2.39	2.02	2.57
medial frontal gyrus, adult, donor10258	10368-105F8	30.18	3.18	0.64	2.22	1.27	0.32	0.64	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	26.02	3.41	7.25	8.10	4.69	3.41	0.85	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	32.40	5.57	7.93	5.74	5.23	1.86	0.68	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	71.31	17.61	5.73	4.88	3.40	1.91	2.12	5.94
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	3.85	5.78	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	28.71	0.00	100.48	43.06	14.35	100.48	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	24.05	1.79	3.59	2.15	1.79	0.72	0.00	1.79
medulla oblongata - adult, donor10196	10174-103C3	22.71	3.24	4.54	12.33	0.65	1.30	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	40.87	17.65	7.74	7.12	5.57	1.24	2.94	2.17
medulla oblongata, adult, pool1	10038-101F2	20.41	8.33	4.82	3.10	2.78	1.31	1.22	0.90
medulla oblongata, newborn, donor10223	10361-105F1	18.40	4.51	3.47	1.74	1.39	0.69	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	25.24	6.64	6.64	13.73	4.43	2.88	2.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	18.34	3.91	3.67	2.57	1.47	1.22	0.12	0.37
melanoma cell line:COLO 679	10514-107E1	7.33	3.45	5.17	6.32	1.44	0.57	0.57	0.43
melanoma cell line:G-361	10465-106H6	8.69	5.97	3.26	2.99	1.09	0.81	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	4.88	6.87	0.90	1.81	0.00	0.00	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	13.22	10.57	6.17	6.17	0.88	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	11.41	6.48	7.52	6.48	7.26	1.30	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	3.53	3.22	3.68	1.23	0.15	0.00	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.45	3.64	3.82	3.82	0.36	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.90	4.14	1.66	2.90	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2.53	3.65	3.65	3.09	0.00	0.00	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.24	4.81	4.24	2.12	1.16	0.39	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	2.78	2.78	3.47	0.69	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2.75	4.81	5.66	1.89	0.51	0.51	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.26	4.26	3.68	2.19	0.92	0.35	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	3.05	3.45	3.32	2.12	0.93	0.40	0.40	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	3.78	5.40	3.65	2.30	0.41	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	2.70	6.83	7.68	2.85	0.85	0.43	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	4.28	5.27	1.32	1.65	0.99	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	3.74	6.50	4.29	3.18	1.11	0.28	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	3.49	2.09	3.14	4.89	0.00	0.00	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.45	3.06	4.08	1.22	1.22	0.00	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.59	3.24	2.16	3.59	0.72	0.36	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.00	3.93	2.90	2.07	0.62	0.10	0.83	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.74	3.42	2.05	1.14	0.68	0.00	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	3.36	2.94	4.20	1.26	0.42	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	4.48	3.74	4.93	2.09	0.60	0.15	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	2.89	4.81	4.03	2.45	0.96	0.26	0.18	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.52	6.26	5.15	2.21	0.74	0.00	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	4.86	3.72	3.15	3.43	1.43	0.86	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	2.95	2.95	0.84	0.00	0.84	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	3.20	2.74	4.11	3.20	0.00	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.60	2.30	3.33	1.02	1.02	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.33	5.50	2.88	1.31	0.00	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	4.93	4.01	1.54	2.16	0.00	0.00	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.24	3.53	2.35	0.71	1.18	0.47	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.43	3.72	4.40	1.02	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.32	3.14	2.75	2.75	0.39	0.39	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.95	3.71	0.93	0.93	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	5.48	3.46	2.31	2.88	0.58	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.13	2.45	2.45	1.34	0.89	0.22	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	3.61	3.12	2.16	1.44	0.24	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	5.87	5.13	2.20	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	2.69	1.68	2.69	0.67	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	1.64	2.87	3.28	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.01	2.15	4.73	1.72	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	5.47	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	5.16	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.20	1.62	3.90	1.30	0.00	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1.45	1.45	4.36	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.20	0.53	2.13	0.53	1.07	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	3.27	3.27	2.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.28	0.78	1.94	1.55	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	0.00	8.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	0.99	3.97	1.99	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.74	2.96	2.37	2.96	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	2.44	2.44	1.22	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	2.53	2.53	3.17	0.63	1.27	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	0.69	1.72	1.38	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	0.00	2.15	2.15	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	2.85	0.41	0.41	0.41	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	0.00	2.38	0.79	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	1.77	0.00	1.77	0.59	0.59	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	0.62	1.56	1.25	0.00	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	0.00	1.34	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	1.18	0.00	1.18	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	2.75	2.07	4.82	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	3.96	2.97	0.99	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	3.36	2.24	4.49	2.24	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	0.64	1.27	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	0.00	0.81	0.00	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	0.00	1.27	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	2.43	3.03	0.00	1.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	6.59	2.47	2.47	3.29	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.77	0.40	2.98	0.99	0.40	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.54	1.95	1.62	0.32	0.00	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	3.06	2.04	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.89	18.57	5.42	1.55	4.64	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	6.38	5.67	3.07	3.54	1.65	0.24	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.96	4.87	6.02	7.41	0.70	0.23	2.32	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	8.55	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	13.05	3.90	2.36	4.93	0.72	0.62	0.41	0.51
mesothelioma cell line:Mero-25	10850-111F4	2.04	2.04	1.36	2.50	1.13	0.23	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	3.91	1.96	3.42	2.20	0.73	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.98	1.55	1.77	1.99	0.66	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	7.36	2.63	3.42	7.36	0.00	0.26	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	11.06	3.23	4.60	3.92	1.53	0.51	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	2.53	0.51	1.77	1.26	0.25	0.00	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	7.66	2.69	0.62	1.24	1.24	0.41	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	11.60	3.81	4.31	4.64	0.83	0.66	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	3.62	1.99	1.27	3.98	0.72	0.18	0.72	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	5.81	3.42	2.22	2.73	0.85	0.34	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	6.87	4.58	3.82	2.04	1.27	0.00	0.76	0.51
mesothelioma cell line:No36	10857-111G2	5.55	1.30	1.63	2.94	1.30	0.33	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	6.23	1.08	1.35	1.90	0.54	0.27	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	10.17	6.33	8.64	7.48	0.77	0.19	0.77	0.38
migratory langerhans cells, donor2	11902-125F3	5.98	7.82	7.45	4.03	1.59	0.24	0.73	0.24
migratory langerhans cells, donor3	11903-125F4	8.97	14.90	5.92	5.38	1.08	0.36	1.08	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.92	3.92	0.65	1.31	0.98	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	4.87	1.70	2.12	1.48	0.42	0.64	1.06	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	25.11	9.91	2.30	1.84	0.46	0.23	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.99	4.76	1.71	1.71	0.57	0.38	1.52	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.57	7.58	6.10	2.40	1.85	1.11	1.29	0.18
myeloma cell line:PCM6	10474-106I6	12.45	1.98	0.79	2.37	0.59	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.45	4.06	3.55	0.51	0.51	0.00	1.01	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.16	5.10	3.73	2.55	0.98	0.39	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2.79	4.79	1.89	2.45	0.45	0.00	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.31	4.49	2.87	2.28	0.37	0.00	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	4.42	2.76	6.07	4.97	0.55	1.66	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	10.35	5.98	9.66	8.28	9.43	1.15	1.61	0.00
neuroblastoma cell line:NB-1	10539-107G8	11.04	12.72	7.67	3.55	5.99	2.06	1.50	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	6.33	3.59	7.17	6.33	3.37	0.42	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	12.30	6.15	7.83	8.39	8.20	2.42	1.30	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.00	8.30	6.41	3.08	3.32	0.71	1.66	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.67	7.76	8.24	3.64	2.38	1.27	4.59	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	9.46	2.82	5.03	4.23	0.60	0.60	0.81	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	6.36	3.81	0.00	4.45	2.54	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	12.24	3.73	2.93	0.53	0.00	0.53	0.27	0.27
neutrophil PMN, donor1	12133-128D9	89.25	312.37	0.00	14.87	0.00	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	13.28	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	9.47	0.00	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	26.21	23.34	36.02	17.93	11.50	1.86	4.57	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	6.40	8.01	16.81	4.00	4.80	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	10.58	1.92	1.60	2.24	0.96	0.32	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.47	1.05	2.89	1.58	0.53	0.26	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	28.68	8.25	3.94	2.91	3.00	1.03	1.31	1.12
occipital cortex - adult, donor10196	10172-103C1	24.72	2.06	10.30	6.18	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	84.00	17.98	7.51	7.25	3.76	2.68	4.56	3.22
occipital cortex, newborn, donor10223	10355-105E4	18.93	1.82	2.55	1.09	5.10	2.18	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	19.42	4.72	4.99	3.67	2.89	2.36	2.10	1.84
occipital lobe, fetal, donor1	10073-102A1	60.07	4.29	11.59	3.00	10.73	8.15	7.72	3.00
occipital pole, adult, pool1	10036-101E9	15.85	4.89	1.34	0.79	2.13	1.02	0.71	0.63
olfactory region, adult	10195-103E6	30.38	6.88	4.59	1.72	2.10	2.67	1.91	1.53
optic nerve, donor1	10277-104E7	62.03	8.00	8.00	6.00	8.00	2.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	10.71	3.87	4.78	4.56	1.25	1.25	0.46	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	4.53	3.57	4.12	7.97	2.61	0.55	0.55	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.43	2.71	0.85	3.22	0.51	0.34	0.68	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.32	3.12	2.54	5.31	0.92	0.46	0.46	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	12.35	4.70	1.76	2.35	1.18	1.47	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	32.70	1.87	0.93	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	17.81	8.27	8.69	1.91	1.48	0.21	0.85	0.85
ovary, adult, pool1	10020-101D2	15.99	12.14	4.80	4.19	4.45	1.14	0.26	1.57
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.27	6.23	3.48	2.38	1.28	0.18	0.73	0.18
pancreas, adult, donor1	10049-101G4	17.87	5.64	2.82	2.82	0.00	0.94	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.43	7.83	0.84	0.56	0.84	0.56	1.96	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	7.50	1.19	0.51	2.04	0.51	0.85	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	12.42	15.07	5.46	9.60	1.32	0.83	0.99	0.33
paracentral gyrus, adult, pool1	10035-101E8	22.51	10.16	4.76	2.29	3.66	1.65	1.01	1.37
parietal cortex, adult, donor10258	10373-105G4	24.96	2.20	2.20	7.34	1.47	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	31.04	11.29	4.70	8.46	0.00	1.88	1.88	5.64
parietal lobe, adult, donor10252	10157-103A4	51.59	14.25	4.56	4.28	2.57	2.85	2.00	2.57
parietal lobe, adult, pool1	10034-101E7	22.47	9.69	3.97	1.59	2.64	1.15	0.62	0.97
parietal lobe, fetal, donor1	10072-101I9	81.47	10.67	11.64	8.73	16.49	5.82	9.70	0.97
parietal lobe, newborn, donor10223	10356-105E5	16.82	3.36	4.49	1.12	3.36	0.75	0.37	0.37
parotid gland, adult	10199-103F1	13.57	7.40	1.85	1.23	0.62	0.62	0.00	0.62
penis, adult	10200-103F2	22.02	8.06	4.30	2.69	2.15	0.54	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.88	3.90	2.97	1.49	2.79	1.67	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	14.28	8.74	2.62	6.12	0.58	0.29	1.31	0.15
pineal gland - adult, donor10196	10179-103C8	61.28	1.94	3.87	23.22	1.94	1.29	0.00	3.23
pineal gland, adult, donor10252	10160-103A7	76.40	11.84	6.51	30.80	2.96	1.18	4.15	3.55
pineal gland, adult, donor10258	10377-105G8	37.00	5.64	3.76	9.41	2.51	1.88	0.63	1.88
pituitary gland - adult, donor10196	10180-103C9	75.89	12.14	10.12	20.24	5.06	1.01	1.01	5.06
pituitary gland, adult, donor10252	10162-103A9	112.05	46.38	16.68	11.47	8.34	6.25	6.25	4.69
pituitary gland, adult, donor10258	10378-105G9	44.26	7.66	3.40	7.66	0.85	3.40	0.85	0.85
placenta, adult, pool1	10021-101D3	14.94	10.11	3.12	1.83	1.18	0.43	0.54	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	8.08	3.05	5.96	2.25	0.66	0.00	0.93	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	11.98	4.51	8.72	5.14	1.56	0.78	1.25	0.93
pons, adult, pool1	10033-101E6	21.26	9.21	5.51	4.22	3.10	1.55	0.77	1.03
postcentral gyrus, adult, pool1	10032-101E5	18.83	6.10	2.01	1.39	2.35	0.87	0.70	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	75.29	52.28	4.18	2.09	4.18	4.18	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	7.43	4.08	5.24	8.45	0.29	0.15	0.73	0.00
prostate cancer cell line:PC-3	10439-106E7	17.06	11.80	9.26	6.72	1.45	0.54	2.36	0.54
prostate, adult, pool1	10022-101D4	12.97	12.52	4.44	3.72	3.26	1.45	0.63	1.00
putamen, adult, donor10196	10176-103C5	48.16	8.03	4.72	4.72	4.49	1.89	1.89	1.42
putamen, adult, donor10252	10152-102I8	27.45	17.65	9.80	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	10.93	3.28	0.00	7.65	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	29.24	6.04	2.90	3.14	1.69	2.17	0.48	1.21
putamen, newborn, donor10223	10365-105F5	21.74	3.00	4.50	2.25	3.00	0.75	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	8.15	9.02	5.53	4.95	2.91	0.58	1.16	0.00
rectum, fetal, donor1	10067-101I4	34.77	4.17	6.95	5.56	4.17	4.17	6.95	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	4.45	1.48	5.30	5.30	1.06	0.42	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.90	6.63	1.24	6.21	2.07	0.41	1.24	0.00
retina, adult, pool1	10030-101E3	32.60	8.85	5.86	8.55	3.28	1.99	1.69	0.89
retinoblastoma cell line:Y79	10475-106I7	16.89	4.68	5.72	30.14	6.75	2.60	4.42	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.79	3.81	4.79	2.21	1.72	0.61	0.74	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	21.65	11.25	18.28	9.84	6.75	2.53	2.81	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	7.58	5.30	0.00	2.27	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	9.23	4.86	5.34	2.75	1.29	0.32	0.16	0.49
salivary acinar cells, donor2	11772-123I8	12.53	2.34	4.68	3.03	1.24	0.28	0.41	0.14
salivary acinar cells, donor3	11773-123I9	58.26	10.59	8.61	5.96	1.32	0.66	0.66	1.99
salivary gland, adult, pool1	10093-102C3	8.01	5.72	0.57	3.43	1.14	0.57	0.00	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.37	2.19	3.20	2.45	2.19	1.26	0.76	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.17	3.53	3.17	2.94	1.06	0.94	0.94	0.24
seminal vesicle, adult	10201-103F3	58.73	13.23	12.70	6.88	6.88	6.35	4.76	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.38	7.04	2.19	3.16	0.24	0.24	1.70	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	3.52	1.01	2.77	0.25	0.25	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	2.01	1.00	2.01	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.22	3.36	3.90	4.97	0.81	1.34	1.21	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	8.95	2.87	3.43	6.19	1.22	0.99	1.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.06	5.55	2.58	5.03	0.26	0.13	0.52	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	5.67	2.13	2.84	1.42	0.00	0.71	2.13
skeletal muscle, adult, pool1	10023-101D5	10.43	10.31	2.28	2.76	1.92	0.72	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	14.07	2.01	4.02	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	54.28	0.00	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	13.89	10.10	6.94	5.68	1.89	3.16	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	11.67	2.33	4.00	1.67	1.33	0.67	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	23.01	14.50	7.25	7.88	5.04	1.89	2.52	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.05	9.06	24.48	5.98	4.63	1.16	0.58	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	15.66	11.37	9.40	8.24	5.44	1.65	0.82	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.63	9.01	5.63	8.85	1.77	0.64	1.13	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	37.48	8.06	3.49	6.10	1.31	1.74	0.22	0.22
small intestine, adult, pool1	10024-101D6	22.22	13.38	9.56	13.02	3.82	1.79	1.91	0.84
small intestine, fetal, donor1	10064-101I1	26.54	2.70	4.42	3.93	0.74	0.98	1.47	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.93	1.54	0.51	3.08	0.51	1.03	2.05	2.05
smooth muscle, adult, pool1	10048-101G3	20.93	3.62	7.50	5.69	1.55	2.07	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	36.99	6.70	4.29	2.41	0.54	1.61	0.00	1.07
spinal cord - adult, donor10196	10181-103D1	33.72	4.36	11.01	5.96	3.90	1.38	0.69	1.84
spinal cord, adult, donor10252	10159-103A6	27.60	12.62	6.31	5.52	5.91	1.18	2.76	0.79
spinal cord, adult, donor10258	10369-105F9	17.29	4.15	6.23	4.15	0.00	1.38	0.69	2.08
spinal cord, fetal, donor1	10056-101H2	20.73	4.88	5.49	3.05	3.05	1.22	3.66	0.61
spinal cord, newborn, donor10223	10359-105E8	12.40	6.89	2.76	5.05	2.30	0.46	1.38	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.90	6.12	3.14	1.34	1.34	0.60	0.00	0.90
spleen, adult, pool1	10025-101D7	30.95	16.30	2.64	3.30	3.19	1.65	0.88	0.66
spleen, fetal, pool1	10044-101F8	19.86	15.33	4.45	1.83	1.91	1.11	0.16	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.52	3.73	2.90	3.31	1.24	0.62	1.14	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.91	11.01	2.28	4.37	1.14	0.57	1.71	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	12.93	4.89	1.40	4.54	0.70	0.00	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	7.04	10.95	0.78	1.17	0.00	0.39	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.88	4.84	1.58	1.01	0.56	0.23	0.79	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.08	8.05	3.39	3.39	0.85	0.42	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	6.35	7.62	0.85	1.27	0.42	0.85	0.42	0.42
stomach, fetal, donor1	10062-101H8	103.59	5.34	8.54	6.41	3.20	5.34	1.07	1.07
submaxillary gland, adult	10202-103F4	27.91	11.96	4.56	2.85	0.00	0.00	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	217.10	0.00	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	36.14	16.62	7.48	5.82	2.08	1.25	3.74	1.04
substantia nigra, adult, donor10258	10371-105G2	19.14	6.21	2.59	4.14	0.52	0.00	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	14.84	4.24	1.41	2.12	7.07	2.83	3.53	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.00	9.40	14.21	6.19	7.57	1.15	1.15	0.69
temporal lobe, adult, pool1	10031-101E4	16.53	5.51	2.12	1.19	2.46	1.02	0.17	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.97	2.85	14.96	4.99	12.82	7.83	6.41	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	35.16	6.15	2.64	4.40	3.96	3.08	4.40	1.32
tenocyte, donor1	11763-123H8	5.24	3.14	2.79	3.84	0.00	0.00	0.00	0.70
tenocyte, donor2	11765-123I1	3.05	1.14	1.91	0.38	0.00	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	5.93	1.85	1.11	2.59	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.23	5.10	6.97	5.78	2.04	0.51	1.02	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	11.10	1.85	4.93	5.55	3.55	0.92	1.70	0.31
teratocarcinoma cell line:PA-1	10807-111A6	4.80	3.87	5.58	4.96	2.63	1.08	0.93	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8.51	9.77	3.05	3.30	1.90	1.02	1.14	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.97	13.61	6.43	4.92	6.05	1.13	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.09	18.10	6.98	4.58	2.62	1.31	0.65	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.86	8.47	3.26	7.49	1.95	1.30	1.95	0.33
testis, adult, pool1	10026-101D8	20.62	13.74	7.73	6.23	6.76	3.54	0.75	1.72
testis, adult, pool2	10096-102C6	37.44	4.96	3.16	12.18	7.22	6.32	1.35	1.35
thalamus - adult, donor10196	10168-103B6	32.02	5.52	8.83	4.42	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	45.48	20.16	6.41	6.10	2.97	2.03	1.88	3.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	29.25	6.16	1.54	0.00	0.00	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.02	2.47	2.47	1.98	0.66	0.66	1.15	0.49
thalamus, newborn, donor10223	10366-105F6	20.14	0.58	1.73	2.88	2.30	1.15	1.15	1.73
throat, adult	10209-103G2	17.48	7.24	3.99	2.50	2.00	1.25	2.75	1.25
throat, fetal, donor1	10061-101H7	35.65	8.84	7.31	4.27	2.13	1.83	3.05	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	8.35	4.17	3.58	3.38	2.19	0.20	2.78	0.00
thymus, adult, pool1	10027-101D9	26.54	30.72	4.57	2.78	7.85	3.88	0.10	0.20
thymus, fetal, pool1	10043-101F7	36.89	42.29	8.42	6.03	10.08	3.64	1.97	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	4.79	4.79	3.32	1.99	0.40	0.27	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	8.80	3.91	1.40	0.56	0.42	0.56	0.70	0.00
thyroid, adult, pool1	10028-101E1	16.98	12.04	4.76	3.92	3.83	0.65	0.37	0.65
thyroid, fetal, donor1	10060-101H6	59.32	6.86	6.06	5.01	0.79	1.32	1.85	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	9.24	6.16	9.24	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	11.86	4.65	5.81	4.42	0.93	0.70	0.93	0.23
tongue, fetal, donor1	10059-101H5	18.52	2.76	2.36	2.76	0.39	0.79	1.18	0.39
tonsil, adult, pool1	10047-101G2	33.16	14.12	6.81	5.11	2.80	2.10	1.80	1.20
trachea, adult, pool1	10029-101E2	15.62	10.96	4.25	2.37	1.88	0.90	0.74	0.74
trachea, fetal, donor1	10058-101H4	39.62	7.31	10.39	8.85	2.31	0.77	3.08	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	5.31	1.77	6.73	1.06	0.35	0.71	0.00	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	13.07	8.71	5.57	4.05	2.63	1.72	0.51	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	8.30	10.50	1.88	3.29	1.41	0.47	1.88	0.47
tridermal teratoma cell line:HGRT	10694-109G1	47.56	15.22	5.71	0.00	0.00	1.90	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.90	6.01	3.39	2.29	0.76	0.85	0.17	0.34
umbilical cord, fetal, donor1	10057-101H3	4.17	6.26	2.09	2.09	0.00	0.00	4.17	2.09
uterus, adult, pool1	10100-102D1	19.28	9.38	3.75	5.46	5.12	1.88	3.41	1.54
uterus, fetal, donor1	10055-101H1	28.16	5.63	8.19	3.58	1.02	0.51	1.54	0.00
vagina, adult	10204-103F6	9.05	14.22	5.17	1.94	7.75	0.65	2.58	3.88
vein, adult	10191-103E2	26.96	9.86	2.41	0.88	2.85	3.29	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.94	3.20	4.01	2.67	0.00	0.27	0.27	0.00